Diseases of the myoneural junction and muscle

G6_MYONEU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G70-G73, G71.10#, G71.11, G71.12, G71.13, G71.14, G71.15, G71.18 Cause of death: ICD-10 — G70-G73, G71.10#, G71.11, G71.12, G71.13, G71.14, G71.15, G71.18 2 out of 7 registries used, show all original rules.	5144
4. Check minimum number of events None	5144
5. Include endpoints G6_MYASTHENIA G6_TOXMYONEU G6_CONDEVMYA G6_MYONEUOTHUNS G6_MUSDYST G6_MYOTDIS G6_CONMYOP G6_MITOCMY G6_MUSCOTHUNS G6_DRUGMYOP G6_ALCOMYOP G6_MYOPTOX G6_PERIOPAR G6_INFLAMYOP G6_MYOPOTHUNS G6_MYOMUSCINOTH	5234
6. Filter based on genotype QC (FinnGen only)	5075

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_MYONEU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_MYASTHENIA\|G6_TOXMYONEU\|G6_CONDEVMYA\|G6_MYONEUOTHUNS\|G6_MUSDYST\|G6_MYOTDIS\|G6_CONMYOP\|G6_MITOCMY\|G6_MUSCOTHUNS\|G6_DRUGMYOP\|G6_ALCOMYOP\|G6_MYOPTOX\|G6_PERIOPAR\|G6_INFLAMYOP\|G6_MYOPOTHUNS\|G6_MYOMUSCINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G7
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G7
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of the myoneural junction and muscle based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42435	19202	22973
Only index persons	37440	17431	20009
Unadjusted period prevalence (%)
Whole population	0.60	0.55	0.64
Only index persons	0.71	0.64	0.76
Median age at first event (years)
Whole population	64.79	68.78	61.48
Only index persons	65.24	69.09	61.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5075	2344	2731
Unadjusted period prevalence (%)	1.06	0.83	1.25
Median age at first event (years)	62.16	60.35	63.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5234: Matched controls
52340

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G72.8

ICD-10 Finland

Other specified myopathies

5157.7

307.7

2630

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.7

307.7

1768

6294

G70.0

ICD-10 Finland

Myasthenia gravis

6280.0

307.7

572

G72.9

ICD-10 Finland

Myopathy, unspecified

2231.0

307.7

1173

108

Kela drug reimbursment

Myasthenia gravis

+∞

307.7

454

NXL00

NOMESCO Finland

Biopsy of muscle

51.3

307.7

212

N07AA02

ATC

pyridostigmine; systemic

223.8

307.7

542

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

51.0

307.7

187

AA1AD

NOMESCO Finland

CT of head and brain

2.9

296.5

2161

10143

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.4

292.5

843

2206

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

50.1

285.7

165

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.7

282.4

715

1688

L28

ICPC

Limited function/disability (L)

3.0

258.6

1507

6184

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

60.2

242.3

135

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.1

228.4

519

1114

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.6

224.6

446

849

G71.08

ICD-10 Finland

Other muscular dystrophy

2134.1

223.4

215

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

+∞

215.1

205

N99

ICPC

Neurological disease other

10.6

202.5

225

221

L04AX01

ATC

azathioprine; systemic

5.1

197.4

442

934

A28

ICPC

Limited function/disability NOS

2.7

192.9

1380

6186

M60.9

ICD-10 Finland

Myositis, unspecified

18.2

182.5

147

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

182.0

1298

5789

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

180.5

2101

11704

N05AH04

ATC

quetiapine; oral

2.7

175.1

1202

5249

M60.8

ICD-10 Finland

Other myositis

38.2

170.6

105

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

169.4

933

3627

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.7

169.4

327

604

M33.2

ICD-10 Finland

Polymyositis

41.2

160.6

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

+∞

158.1

151

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

157.6

1773

9620

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.0

155.8

467

1237

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

155.0

573

1753

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.0

154.0

280

488

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

10.4

153.0

171

169

R53

ICD-10 Finland

Malaise and fatigue

2.3

151.1

1547

8045

N03AE01

ATC

clonazepam; systemic

3.8

150.7

505

1446

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.6

150.0

538

1612

N05AH03

ATC

olanzapine; systemic

3.7

145.3

503

1471

SPAT1229

SPAT

Assessment of need for aid

3.1

145.3

664

2312

SPAT1216

SPAT

Assessment of functional ability

2.5

142.2

1141

5312

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.4

141.1

565

1815

N05AA02

ATC

levomepromazine; systemic

4.3

135.4

372

922

N03AG01

ATC

valproic acid; systemic, rectal

3.6

134.3

479

1427

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.0

133.8

242

419

N07AA03

ATC

distigmine; systemic

23.0

133.5

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.8

131.3

209

318

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

129.8

1085

5123

G71.18

ICD-10 Finland

Other myotonic disease

327.5

128.0

129

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

127.3

1013

4674

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

+∞

125.5

120

SPAT1254

SPAT

Administration of medicine

2.4

125.0

1040

4892

N28

ICPC

Limited function/disability (N)

6.4

124.7

212

345

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.2

124.5

216

359

N05BA01

ATC

diazepam; systemic, rectal

2.5

122.6

902

4009

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

121.4

775

3215

R1250

NOMESCO Finland

Evaluation of functional capability

5.4

120.6

244

469

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

118.1

2692

18437

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

6.4

118.1

199

321

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

399.7

118.1

118

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.6

115.1

223

412

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

8.3

114.1

151

186

N05AF03

ATC

chlorprothixene; systemic

5.2

114.1

242

485

G71.8

ICD-10 Finland

Other primary disorders of muscles

+∞

114.0

109

F10.24

ICD-10 Finland

Alcohol depence active use

7.0

113.5

175

257

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

+∞

112.9

108

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

112.6

758

3220

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

112.3

1089

5447

C03CA01

ATC

furosemide; systemic

2.0

112.0

1974

12337

R03CA02

ATC

ephedrine; oral

34.3

111.9

N03AX16

ATC

[U] pregabalin

2.1

111.7

1415

7859

G71.12

ICD-10 Finland

Myotonia congenita

+∞

110.8

106

H53.2

ICD-10 Finland

Diplopia

4.2

110.3

306

762

Z31.5

ICD-10 Finland

Genetic counselling

3.7

109.7

365

1035

N06AX11

ATC

mirtazapine; oral

2.0

108.6

1917

11955

G72.0

ICD-10 Finland

Drug-induced myopathy

1070.3

107.8

105

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.8

106.8

614

2407

N05CD07

ATC

temazepam; oral

2.4

105.5

838

3838

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.0

105.1

189

325

SPAT1172

SPAT

Guidance concerning hydration

4.8

104.1

242

524

N05AX08

ATC

risperidone; systemic

2.7

103.8

621

2483

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.9

103.5

322

871

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

103.1

918

4415

SPAT1234

SPAT

Support of social functional capacity

3.2

102.9

438

1452

N03AX09

ATC

lamotrigine; oral

3.8

102.4

332

924

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

101.2

385

1191

N07BB01

ATC

disulfiram; oral

3.7

99.6

330

932

N06AB04

ATC

citalopram; systemic

2.1

99.3

1227

6710

P15

ICPC

Chronic alcohol abuse

4.4

97.8

254

601

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.0

97.6

175

300

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

97.5

1901

12150

N29

ICPC

Neurological sympt/complt other

5.3

97.3

201

393

N05BA04

ATC

oxazepam; oral

2.0

97.0

1496

8843

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

11.4

95.0

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

128.7

94.3

101

N17.8

ICD-10 Finland

Other acute renal failure

6.7

93.8

151

232

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.1

93.6

115

129

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

93.4

463

1673

E86

ICD-10 Finland

Volume depletion

4.3

93.0

246

590

H02.4

ICD-10 Finland

Ptosis of eyelid

4.2

92.8

256

634

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

15.6

92.3

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.3

90.9

355

1115

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

89.4

525

2073

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

87.9

866

4320

N03AX12

ATC

[U] gabapentin; oral

2.1

87.2

980

5145

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.4

86.6

327

1005

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.7

85.2

202

444

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

84.4

626

2763

N06AX21

ATC

duloxetine; oral

2.3

83.8

690

3189

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.7

82.9

197

434

A04

ICPC

Weakness/tiredness general

2.1

80.5

890

4630

N06AX16

ATC

venlafaxine; oral

2.2

80.5

768

3772

A46

ICD-10 Finland

Erysipelas

2.1

80.4

927

4899

Z2446

NOMESCO Finland

Social worker

2.8

80.3

446

1709

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

78.4

1082

6094

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.5

76.3

270

795

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

75.6

1570

10062

S01.0

ICD-10 Finland

Open wound of scalp

2.4

75.5

547

2383

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.0

74.5

349

1218

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.7

74.2

175

383

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

74.1

799

4108

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.5

73.9

185

425

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

73.6

379

1394

WX892

NOMESCO Finland

Monitored bed care

2.5

73.6

516

2214

W19

ICD-10 Finland

Unspecified fall

2.3

73.3

630

2956

N05AH02

ATC

clozapine; systemic

5.3

73.3

149

287

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

73.1

1615

10521

N04AA02

ATC

biperiden; systemic

5.0

72.6

159

327

T68

ICD-10 Finland

Hypothermia

10.7

72.5

TAB00

NOMESCO Finland

Lumbar puncture

3.2

72.2

304

997

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

72.1

584

2671

N05CF01

ATC

zopiclone; oral

1.7

71.9

1790

12049

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.5

71.9

118

185

R13

ICD-10 Finland

Dysphagia

2.5

71.8

471

1957

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.0

71.5

109

158

ZXD05

NOMESCO Finland

Urgent procedure

1.8

71.2

1645

10838

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.6

70.0

241

697

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

69.9

492

2112

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

69.5

497

2149

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

69.5

210

555

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

68.8

532

2383

Z3226

NOMESCO Finland

Physiotherapist

1.9

68.7

1053

6112

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

68.5

783

4105

E87.6

ICD-10 Finland

Hypokalaemia

3.4

68.4

257

786

F05.9

ICD-10 Finland

Delirium, unspecified

4.0

68.4

199

512

S97

ICPC

Chronic ulcer skin

2.6

67.8

423

1715

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

67.6

256

787

N06AA09

ATC

amitriptyline; systemic

2.3

66.9

591

2801

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

14.0

66.4

M62.8

ICD-10 Finland

Other specified disorders of muscle

13.1

64.8

N05BA02

ATC

chlordiazepoxide; systemic

3.9

64.7

198

528

S06.0

ICD-10 Finland

Concussion

2.2

64.6

637

3153

A41.9

ICD-10 Finland

Sepsis, unspecified

3.1

63.4

283

960

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.6

63.3

102

157

A06AD11

ATC

lactulose; oral

1.9

63.2

913

5183

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

62.9

948

5456

TNX05

NOMESCO Finland

Simple incision of soft tissue, unspecified region

19.0

62.3

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

+∞

61.6

H02AB06

ATC

prednisolone; systemic

1.6

61.3

2457

18497

R60.0

ICD-10 Finland

Localized oedema

2.0

60.6

723

3839

G72.4

ICD-10 Finland

Inflammatory myopathy, not elsewhere classified

+∞

60.5

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

59.9

548

2629

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

59.7

144

321

TK800

NOMESCO Finland

Hemodialysis

3.9

59.4

177

463

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

59.2

352

1391

L99

ICPC

Musculoskeletal disease other

4.1

59.2

167

420

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

58.7

780

4297

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

58.7

662

3442

N05AX12

ATC

aripiprazole; systemic

3.3

58.2

225

700

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

58.0

442

1962

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

9.6

57.7

N03AF01

ATC

carbamazepine; oral, rectal

2.7

57.6

337

1321

3580A

ICD-9 Finland

Myoneural disorders, Myasthenia gravis

+∞

57.4

A02BC02

ATC

pantoprazole; systemic

1.6

56.9

3454

28503

SPAT1301

SPAT

No procedures

1.6

56.6

1649

11412

SPAT1167

SPAT

Insertion of urinary catheter

3.1

56.6

245

816

N06AB03

ATC

fluoxetine; oral

2.0

56.6

647

3378

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.2

56.5

155

382

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.4

56.3

111

208

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

56.1

371

1544

N02AA05

ATC

oxycodone; systemic

1.8

55.7

1022

6229

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

55.2

842

4848

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.6

54.9

335

1340

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

54.4

466

2173

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

54.3

315

1229

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

53.1

461

2161

N18

ICPC

Paralysis/weakness

3.8

52.7

163

438

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

51.5

1160

7475

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.2

51.4

144

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

51.4

549

2790

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

51.3

248

879

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

51.1

322

1308

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

10.5

50.8

N06AA12

ATC

doxepin; systemic

2.6

50.7

320

1301

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.7

50.6

162

446

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

7.2

49.9

104

N02AX02

ATC

tramadol; systemic, rectal

1.6

49.9

2194

16609

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.3

49.7

100

191

N05BE01

ATC

buspirone; oral

3.3

49.6

192

598

J96.1

ICD-10 Finland

Chronic respiratory failure

3.5

49.6

175

514

R4110

NOMESCO Finland

Physiotherapy

1.6

49.5

1431

9819

G70

ICD-10 Finland

Myasthenia gravis and other myoneural disorders

492.5

49.5

L19

ICPC

Muscle symptom/complaint NOS

3.3

49.4

191

594

WX730

NOMESCO Finland

Conventional respirator

4.4

49.1

126

295

73300

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Myasthenia gravis

+∞

49.0

N05AD01

ATC

haloperidol; systemic

3.0

48.5

217

736

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

13.7

48.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

48.3

426

2008

N02BE01

ATC

paracetamol; systemic, rectal

1.8

48.1

4496

40327

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.3

47.9

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.8

47.8

245

896

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.6

47.7

157

440

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.3

47.5

184

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

47.3

400

1852

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

47.1

431

2061

N03AX14

ATC

levetiracetam; systemic

3.1

47.1

197

643

M62.5

ICD-10 Finland

Muscle wasting and atrophy, not elsewhere classified

16.1

46.9

N05AN01

ATC

lithium; oral

3.7

46.9

152

422

Z72.1

ICD-10 Finland

Alcohol use

4.9

46.8

103

213

R06.0

ICD-10 Finland

Dyspnoea

1.6

46.4

1396

9646

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.2

46.2

192

624

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

46.2

687

3907

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.3

45.7

N05BA12

ATC

alprazolam; oral

2.0

45.6

538

2829

H02AB07

ATC

prednisone; oral

1.8

44.3

729

4276

R50.9

ICD-10 Finland

Fever, unspecified

1.8

44.1

794

4781

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.9

44.0

215

766

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

96.9

43.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

43.6

889

5545

N06AB06

ATC

sertraline; oral

2.0

43.4

541

2899

N05AA01

ATC

chlorpromazine; systemic, rectal

4.6

43.3

104

231

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.3

43.3

165

509

R4120

NOMESCO Finland

Occupational therapy

2.2

43.2

374

1747

N05AB03

ATC

perphenazine; systemic, rectal

2.9

43.0

212

759

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

42.8

483

2498

P16

ICPC

Acute alcohol abuse

4.2

42.6

115

280

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.3

42.6

110

259

N06AB10

ATC

escitalopram; oral

1.7

42.4

920

5832

Z3231

NOMESCO Finland

Registered nurse

1.6

42.4

1408

9923

C07AB07

ATC

bisoprolol; oral

1.5

42.2

2532

20221

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

42.1

623

3532

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.8

41.9

130

350

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

41.9

370

1742

SPAT1240

SPAT

Therapeutic discussion

2.0

41.8

472

2442

SPAT1263

SPAT

Sampling

1.5

41.5

2027

15509

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.8

41.4

130

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

41.3

1121

7522

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.9

41.2

185

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.5

41.0

101

229

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

41.0

148

441

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

40.9

334

1522

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.8

40.8

194

R42

ICD-10 Finland

Dizziness and giddiness

1.6

40.7

1166

7923

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.0

40.5

184

630

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

40.1

518

2806

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

40.0

617

3540

L04AA06

ATC

mycophenolic acid; systemic

3.7

39.7

128

354

G71.0

ICD-10 Finland

Muscular dystrophy

+∞

39.6

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.6

39.6

207

R4130

NOMESCO Finland

Speech therapy

3.1

39.5

173

580

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.4

39.4

228

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.8

39.4

E0000UV, ,

ATC

1.5

39.3

1967

15075

F34.1

ICD-10 Finland

Dysthymia

2.8

39.3

197

712

C07AA05

ATC

propranolol; systemic

1.7

39.2

930

6024

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.5

39.2

221

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

39.2

243

979

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

64.8

39.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

38.9

914

5905

M79.1

ICD-10 Finland

Myalgia

1.8

38.8

673

3998

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

38.8

367

1775

G72.1

ICD-10 Finland

Alcoholic myopathy

+∞

38.6

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.1

38.6

107

266

N06AX03

ATC

mianserin; oral

2.4

38.4

281

1221

R55

ICD-10 Finland

Syncope and collapse

1.8

38.1

614

3567

G72

ICD-10 Finland

Other myopathies

380.2

38.1

N05AC02

ATC

thioridazine; oral

3.6

37.8

127

361

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.9

37.8

179

627

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.7

37.8

191

3599X

ICD-9 Finland

Muscular dystrophies and other myopathies, Myopathy, unspecified

+∞

37.5

G70.8

ICD-10 Finland

Other specified myoneural disorders

+∞

37.5

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

37.5

244

1005

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.9

37.3

J01FF01

ATC

clindamycin; systemic

1.5

37.2

1309

9298

E87.2

ICD-10 Finland

Acidosis

6.4

37.1

R33

ICD-10 Finland

Retention of urine

1.9

36.9

479

2596

N05AF05

ATC

zuclopenthixol; systemic

5.3

36.9

141

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

36.8

172

598

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

5.2

36.7

149

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

36.7

353

1718

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.5

36.6

200

R5110, ,

SPAT

2.1

36.6

363

1788

G71.28

ICD-10 Finland

Other congenital myopathy

+∞

36.5

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

36.4

824

5264

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.6

36.2

213

836

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

36.1

139

432

M79.6

ICD-10 Finland

Pain in limb

1.5

36.0

1941

15024

N02BF02

ATC

pregabalin; oral

2.2

36.0

308

1431

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

35.9

189

701

M03BX01

ATC

baclofen; systemic

3.4

35.9

128

379

N03AF02

ATC

oxcarbazepine; oral

2.7

35.7

194

732

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.9

35.6

Y94.0

ICD-10 Finland

Accident at home

3.4

35.4

130

392

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

35.4

436

2322

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

35.3

595

3501

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

35.3

506

2833

Z72.2

ICD-10 Finland

Drug use

7.2

35.1

V03AA01, ,

ATC

3.7

35.0

113

313

WX882

NOMESCO Finland

High dependency care

2.8

34.8

178

650

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

34.8

228

942

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.8

34.7

J01DB01

ATC

cefalexin; oral

1.5

34.7

4063

36310

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

34.4

178

654

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.3

34.4

134

419

M48.0

ICD-10 Finland

Spinal stenosis

1.7

34.3

653

3976

S18

ICPC

Laceration/cut

1.4

34.3

2216

17697

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

34.3

397

2068

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

34.3

376

1921

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

34.2

824

5341

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.5

34.0

183

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.9

33.9

152

P72

ICPC

Schizophrenia

3.5

33.9

117

339

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

9.2

33.9

M05BA04

ATC

alendronic acid; oral

1.9

33.9

471

2610

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.5

33.8

188

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

33.7

263

1176

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.7

33.4

107

295

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

8.0

33.2

P99

ICPC

Psychological disorders other

3.0

33.0

152

525

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

32.6

955

6482

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

32.6

573

3408

A01

ICPC

Pain general/multiple sites

1.9

32.6

465

2596

P29

ICPC

Psychological sympt/compl other

2.2

32.5

298

1422

A02BC01

ATC

omeprazole; systemic

1.5

32.4

1340

9800

SPAT1125

SPAT

Stoma care and guidance

3.4

32.4

120

364

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

32.3

G71.06

ICD-10 Finland

Muscular dystrophy severe [Duchenne]

+∞

32.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

32.3

524

3044

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

32.3

504

2895

N30.0

ICD-10 Finland

Acute cystitis

1.7

32.2

744

4768

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.6

31.9

164

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.9

31.8

145

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

31.5

240

1062

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

31.4

459

2581

F61.0

ICD-10 Finland

Mixed personality disorders

3.9

31.4

234

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

31.3

502

2905

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

31.3

155

557

5872

FHL

Thymic exploration or thymectomy

+∞

31.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

31.1

311

1536

A12BA01

ATC

potassium chloride; oral

2.2

31.1

270

1262

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

31.0

1423

10610

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

7.1

30.9

A29

ICPC

General symptom/complaint other

1.7

30.9

635

3943

N05CF02

ATC

zolpidem; oral

1.6

30.7

798

5259

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

30.7

286

1374

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

10.4

30.7

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

10.7

30.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

30.4

162

605

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.1

30.3

124

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

8.2

30.3

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

30.1

1229

8945

X58

ICD-10 Finland

Exposure to other specified factors

1.7

29.9

662

4188

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

29.9

1165

8394

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

10.4

29.8

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

4.9

29.7

134

WX872

NOMESCO Finland

Intensive care

2.1

29.4

288

1410

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

29.3

1707

13276

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

29.2

162

618

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.0

29.2

215

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

29.1

441

2506

C03DA01

ATC

spironolactone; oral

1.7

29.1

632

3980

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.4

29.0

105

314

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

28.9

282

1378

GEC23

NOMESCO Finland

Transsternal thymectomy

44.0

28.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

28.6

212

926

R51.80

ICD-10 Finland

Headache

1.6

28.5

671

4311

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

6.7

28.4

SPAT1262

SPAT

Handing over of treatment supplies

1.6

28.4

880

6032

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.4

28.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

28.4

625

3947

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

28.4

386

2121

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

28.3

429

2440

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

+∞

28.1

K08.3

ICD-10 Finland

Retained dental root

1.9

28.1

390

2156

H02AB09

ATC

hydrocortisone; systemic

2.8

28.1

140

505

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

28.0

351

1876

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

27.8

513

3088

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

27.7

263

1272

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

27.7

544

3332

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

27.6

167

665

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

27.5

186

780

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

27.5

354

1909

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

27.4

1864

14845

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

27.4

401

2255

F31

ICD-10 Finland

Bipolar affective disorder

4.3

27.4

164

D21

ICPC

Swallowing problem

3.3

27.3

103

316

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.3

27.3

217

977

XA402

NOMESCO Finland

ENMG

2.8

27.3

140

513

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.3

27.2

102

312

SPAT1227

SPAT

Substance abuse rehabilitation

6.1

27.1

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.2

27.1

L76

ICPC

Fracture: other

2.5

27.1

174

713

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.5

27.1

269

ZY000

NOMESCO Finland

Hospital inpatient

3.9

27.0

209

N06AX26

ATC

vortioxetine; oral

2.0

27.0

311

1615

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

27.0

226

1040

J01MA12

ATC

levofloxacin; systemic

1.5

27.0

914

6380

ZZA00

NOMESCO Finland

Split skin graft

2.5

27.0

170

690

R52.2

ICD-10 Finland

Other chronic pain

2.4

27.0

194

837

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

23.9

26.9

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

26.8

143

535

P01BA02

ATC

hydroxychloroquine; oral

1.9

26.7

384

2147

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

26.6

251

1211

M54.5

ICD-10 Finland

Low back pain

1.4

26.6

1593

12401

R27.0

ICD-10 Finland

Ataxia, unspecified

6.2

26.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

26.5

630

4054

JN4AD

NOMESCO Finland

Body CT examination

1.7

26.4

499

3023

SPAT1265

SPAT

Breathalyser

4.4

26.4

152

UJF32

NOMESCO Finland

Coloscopy

1.4

26.3

1244

9277

AA1XD

NOMESCO Finland

Other special CT of head and brain

6.8

26.3

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

26.3

306

1595

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

10.4

26.2

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.4

26.1

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.8

26.1

132

480

P03

ICPC

Feeling depressed

1.8

26.1

376

2103

Z2221

NOMESCO Finland

Medical doctor

1.4

26.1

1253

9370

G71.02

ICD-10 Finland

Muscular dystrophy facioscapulohumeral

+∞

26.1

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

26.0

119

410

N05CD02

ATC

nitrazepam; oral

3.1

26.0

108

352

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.9

25.9

202

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

25.7

1605

12570

P18

ICPC

Medication abuse

5.0

25.6

108

N05AL01

ATC

sulpiride; systemic

3.4

25.5

275

RS142, ,

NOMESCO Finland

9.4

25.3

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.7

25.2

134

500

N06AX05

ATC

trazodone; oral

2.7

25.1

132

490

N03AX18

ATC

lacosamide; systemic

4.9

25.1

110

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

25.0

215

1000

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

25.0

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

+∞

25.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

24.9

1202

8984

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.8

24.9

128

470

Z50.1

ICD-10 Finland

Other physical therapy

2.0

24.8

273

1395

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.2

24.8

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.5

24.8

164

682

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.5

24.7

131

XF404

NOMESCO Finland

Ambulatory ECG

1.7

24.7

444

2652

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

24.7

1285

9736

ZY010

NOMESCO Finland

Hospital outpatient

2.1

24.6

229

1099

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

24.6

866

6085

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

7.0

24.6

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

7.2

24.6

X31

ICD-10 Finland

Exposure to excessive natural cold

7.2

24.6

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

8.7

24.5

SPAT1139

SPAT

Nutrition survey

2.3

24.5

181

791

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.8

24.4

R25.2

ICD-10 Finland

Cramp and spasm

2.7

24.3

134

510

SPAT1211

SPAT

Application of soft bandage

1.7

24.3

427

2534

6BA02, ,

NOMESCO Finland

7.9

24.3

Z08

ICPC

Social welfare problem

3.6

24.2

221

A08

ICPC

Swelling

2.0

24.2

264

1345

SPAT1360

SPAT

Extensive global examination

1.9

24.2

344

1916

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.9

24.2

N03AB02

ATC

phenytoin; systemic

3.6

24.1

222

SPAT1252

SPAT

Overall medication plan or its review

1.8

24.0

352

1978

N02BF01

ATC

gabapentin; oral

1.8

24.0

375

2149

G72.3

ICD-10 Finland

Periodic paralysis

+∞

24.0

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

22.8

23.9

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

6.0

23.8

G56.3

ICD-10 Finland

Lesion of radial nerve

4.5

23.8

127

G70.28

ICD-10 Finland

Other congenital and developmental myasthenia

241.1

23.7

SPAT1053

SPAT

Memory test

1.5

23.6

737

5042

G12.2

ICD-10 Finland

Motor neuron disease

4.9

23.6

108

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

23.6

175

766

R11

ICD-10 Finland

Nausea and vomiting

1.8

23.6

401

2357

N06AA06

ATC

trimipramine; systemic

2.6

23.5

132

507

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

23.5

132

507

XG466

NOMESCO Finland

Sleep oxymetry

2.4

23.5

169

730

SPAT1260

SPAT

Consultation of another employee

1.5

23.5

804

5612

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

23.4

1956

15990

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

23.3

476

2942

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.2

23.3

286

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

23.3

1193

8998

TK810

NOMESCO Finland

Hemofiltration

5.0

23.2

T51.0

ICD-10 Finland

Toxic effect: Ethanol

6.2

23.1

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.3

23.0

273

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

23.0

541

3467

G70.20

ICD-10 Finland

Congenital and developmental myasthenia

+∞

22.9

F03

ICD-10 Finland

Unspecified dementia

2.0

22.9

240

1206

G71.1

ICD-10 Finland

Myotonic disorders

65.3

22.8

R40.2

ICD-10 Finland

Coma, unspecified

3.9

22.8

170

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

22.8

249

1270

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

22.7

404

2404

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

22.7

346

1968

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

22.6

420

2529

H03AA01

ATC

levothyroxine sodium; systemic

1.4

22.6

1006

7389

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

22.6

1910

15619

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

22.5

106

371

N05AB01

ATC

dixyrazine; systemic

3.6

22.5

213

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

22.5

102

350

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

7.0

22.5

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.8

22.4

115

422

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

32.4

22.4

RS221, ,

NOMESCO Finland

3.2

22.3

278

OAB43, ,

SPAT

0.6

22.3

439

6894

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

22.3

204

974

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

8.3

22.2

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.4

22.2

239

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

22.2

362

2102

S22.3

ICD-10 Finland

Fracture of rib

1.8

22.1

362

2103

Z2445

NOMESCO Finland

Psychologist

2.2

22.1

179

813

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.1

22.0

ZXE00

NOMESCO Finland

One hour or less

1.4

22.0

1757

14231

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.7

21.9

122

467

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

21.9

208

1007

G73.1*C80.99

ICD-10 Finland

Eaton-Lambert syndrome

+∞

21.9

2AB04, ,

NOMESCO Finland

8.5

21.9

N06AA10

ATC

nortriptyline; systemic

2.8

21.8

110

400

J01EA01

ATC

trimethoprim; systemic

1.4

21.6

1139

8616

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

21.6

814

5786

N05AE04

ATC

ziprasidone; systemic

6.1

21.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

21.5

634

4278

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.3

21.5

129

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.9

21.5

100

348

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

21.5

279

1509

P19

ICPC

Drug abuse

4.5

21.4

113

A02BC05

ATC

esomeprazole; systemic

1.3

21.4

1840

15055

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

21.1

308

1730

G04BD12

ATC

mirabegron; oral

1.6

21.0

558

3676

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

21.0

263

1405

B01AB05

ATC

enoxaparin; parenteral

1.4

21.0

1445

11420

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.8

20.9

167

P20

ICPC

Memory disturbance

1.5

20.9

688

4756

3591A

ICD-9 Finland

Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy

+∞

20.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

20.8

540

3541

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.9

20.7

159

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.2

20.7

133

G47.3

ICD-10 Finland

Sleep apnoea

1.4

20.7

1007

7506

J01DA01

ATC

[U] cefalexin

1.3

20.6

2858

24976

S70.0

ICD-10 Finland

Contusion of hip

2.1

20.5

205

1012

A41.8

ICD-10 Finland

Other specified sepsis

2.7

20.5

111

419

P28

ICPC

Limited function/disability (P)

4.1

20.4

139

R52.9

ICD-10 Finland

Pain, unspecified

1.7

20.3

430

2679

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.3

20.3

238

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.2

20.3

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

20.2

252

1344

N06AG02

ATC

moclobemide; oral

2.1

20.2

201

990

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

20.2

171

791

RD210, ,

NOMESCO Finland

2.8

20.2

349

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

20.1

1588

12796

U04

ICPC

Incontinence urine

1.9

20.0

269

1471

G73.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic amyotrophy

+∞

19.8

G72.2

ICD-10 Finland

Myopathy due to other toxic agents

+∞

19.8

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

19.7

293

1653

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

19.7

461

2946

WW400

NOMESCO Finland

Plasmaferesis

15.3

19.7

H25.8

ICD-10 Finland

Other senile cataract

1.6

19.7

552

3682

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

19.6

1716

14027

EBA00

NOMESCO Finland

Extraction of tooth

1.3

19.6

1541

12400

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.4

19.6

113

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

19.5

544

3623

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

19.4

174

824

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.9

19.4

J01MA02

ATC

ciprofloxacin; systemic

1.3

19.4

1828

15098

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

6.1

19.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

19.3

3211

28648

N06AX12

ATC

bupropion; oral

1.9

19.3

258

1409

R4190

NOMESCO Finland

Nutritional therapy

2.1

19.3

175

833

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.2

19.3

166

774

A99

ICPC

Disease/condition unspecnature/site

1.6

19.2

429

2709

R02

ICPC

Shortness of breath/dyspnoea

1.5

19.2

585

3974

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.9

19.1

321

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.7

19.1

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.1

19.1

124

H50.2

ICD-10 Finland

Vertical strabismus

4.2

19.0

120

M33.1

ICD-10 Finland

Other dermatomyositis

20.1

19.0

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

19.0

558

3760

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.5

18.9

104

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.1

18.9

254

F22.0

ICD-10 Finland

Delusional disorder

3.0

18.9

275

L29

ICPC

Musculoskeletal sympt/complt other

1.7

18.9

381

2345

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

18.8

1555

12595

G70.1

ICD-10 Finland

Toxic myoneural disorders

+∞

18.8

G60.0

ICD-10 Finland

Hereditary motor and sensory neuropathy

8.1

18.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

18.7

476

3102

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

7.7

18.7

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

18.7

477

3113

F20

ICD-10 Finland

Schizophrenia

4.5

18.7

101

H26.3

ICD-10 Finland

Drug-induced cataract

4.6

18.6

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

18.6

326

1930

SPAT1153

SPAT

Removal of sutures

1.3

18.6

1439

11534

E000001, ,

ATC

1.4

18.6

854

6286

SPAT1251

SPAT

Organisation of medication

2.1

18.5

185

913

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

18.5

496

3271

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

18.5

108

424

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

18.5

233

1249

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

18.4

141

626

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.2

18.4

N87

ICPC

Parkinsonism

2.8

18.4

334

C09AA05

ATC

ramipril; oral

1.4

18.3

1218

9541

S01XA18

ATC

ciclosporin; ophthalmic

4.3

18.2

107

H02AB04

ATC

methylprednisolone; systemic

1.5

18.2

633

4416

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

25.1

18.2

L75

ICPC

Fracture: femur

2.9

18.2

281

UKC02

NOMESCO Finland

Cystoscopy

1.4

18.2

789

5748

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

18.1

231

1242

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

18.1

220

1164

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

18.1

313

1847

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

18.1

205

1060

K07

ICPC

Swollen ankles/oedema

1.9

17.9

236

1282

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.6

17.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

17.9

373

P01

ICPC

Feeling anxious/nervous/tense

1.6

17.8

395

2489

N03AX11

ATC

topiramate; oral

2.6

17.8

100

385

GEC26

NOMESCO Finland

Mediastinoscopic thymectomy

+∞

17.7

A02BC03

ATC

lansoprazole; oral

1.3

17.7

1295

10282

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

17.7

1114

8643

K59.0

ICD-10 Finland

Constipation

1.8

17.6

262

1479

P76

ICPC

Depressive disorder

1.9

17.5

242

1335

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

17.4

104

413

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

7.4

17.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

17.3

514

3467

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

17.3

1998

16890

M79.7

ICD-10 Finland

Fibromyalgia

2.3

17.3

135

605

SPAT1310

SPAT

Counselling related to known health issue

1.3

17.2

1382

11114

IGV01

NOMESCO Finland

Psychiatric network contact

3.7

17.2

143

R1260

NOMESCO Finland

Evaluation of communicative skills

2.7

17.1

358

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

17.1

157

751

L04AX03

ATC

methotrexate; systemic

1.6

17.1

411

2642

RS222, ,

NOMESCO Finland

3.1

17.1

227

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.8

17.1

291

5CM18, ,

NOMESCO Finland

5.8

17.1

Z03

ICPC

Housing/neighbourhood problem

3.9

17.0

126

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.8

17.0

G35

ICD-10 Finland

Multiple sclerosis

3.1

17.0

238

L17

ICPC

Foot/toe symptom/complaint

1.3

17.0

1251

9930

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

6.6

17.0

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

17.0

277

1607

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

17.0

1125

8790

OAA80, ,

SPAT

0.4

16.9

1909

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.4

16.9

114

479

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.3

16.9

193

N06AB05

ATC

paroxetine; oral

1.8

16.9

244

1366

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.3

16.9

101

Y96.9

ICD-10 Finland

Unspecified type of accident

2.6

16.8

373

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

16.8

750

5485

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

16.8

256

1457

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.4

16.8

119

512

RS220, ,

NOMESCO Finland

3.0

16.8

235

G40

ICD-10 Finland

Epilepsy

3.7

16.7

146

Z50.5

ICD-10 Finland

Speech therapy

3.0

16.7

246

Z00.0

ICD-10 Finland

General medical examination

1.4

16.7

846

6326

A10AB05

ATC

insulin aspart; parenteral

1.6

16.7

364

2285

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.0

16.7

241

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.5

16.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

16.6

2932

26100

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

16.6

222

1213

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.9

16.6

C08CA01

ATC

amlodipine; oral

1.3

16.6

1822

15280

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

16.6

598

4201

G73.7*M34.8

ICD-10 Finland

Myopathy in scleroderma

90.4

16.6

G93.4

ICD-10 Finland

Encephalopathy, unspecified

7.0

16.5

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

7.3

16.5

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

16.3

16.5

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

16.5

322

1965

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.2

16.5

135

618

WX722

NOMESCO Finland

PEEP

1.9

16.4

222

1217

G04BD08

ATC

solifenacin; oral

1.7

16.4

313

1897

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

16.4

129

580

N05BA09

ATC

clobazam; oral

4.6

16.3

G24.9

ICD-10 Finland

Dystonia, unspecified

6.3

16.3

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

16.2

256

N04BC05

ATC

pramipexole; oral

1.6

16.2

346

2161

RF120, ,

NOMESCO Finland

3.1

16.2

219

ZX120

NOMESCO Finland

Intravenous

1.6

16.1

427

2807

R03AC02

ATC

salbutamol; inhalant

1.3

16.1

2409

20977

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

6.8

16.1

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

16.1

282

1670

SPAT1104

SPAT

Monitoring of emergency patient

1.7

16.1

303

1831

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

16.1

135

624

R52.1

ICD-10 Finland

Chronic intractable pain

3.5

16.0

155

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

16.0

541

3748

Z71.8

ICD-10 Finland

Other specified counselling

1.3

16.0

1268

10160

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

16.0

317

1941

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.6

16.0

365

K85

ICD-10 Finland

Acute pancreatitis

2.6

16.0

342

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

15.9

282

1675

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

15.9

151

732

B01AA03

ATC

warfarin; systemic

1.4

15.9

969

7466

L84

ICD-10 Finland

Corns and callosities

2.0

15.9

165

828

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

14.5

15.8

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

15.7

113

489

X84

ICD-10 Finland

Intentional self-harm by unspecified means

6.6

15.7

XKC03

NOMESCO Finland

Water cystometry

2.1

15.7

144

689

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

6.9

15.7

33030

ICD-8 Finland

Hereditary neuromuscular disorders, Progressive muscular dystrophy

+∞

15.6

G70.21

ICD-10 Finland

Limb girdle myasthenia

+∞

15.6

OAA67, ,

SPAT

0.5

15.6

183

3323

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

15.6

257

1496

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

15.6

166

840

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

15.6

104

436

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

15.6

164

827

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

5.6

15.5

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

15.5

210

1152

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

11.7

15.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.1

15.5

209

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

15.5

352

2233

L03

ICPC

Low back symptom/complaint

1.3

15.4

1131

8954

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

15.4

1192

9510

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

15.4

214

1184

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.6

15.3

136

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.1

15.3

145

703

29999

ICD-8 Finland

Unspecified psychosis

5.2

15.3

C01BB02

ATC

mexiletine; systemic

6.7

15.3

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

15.3

111

483

NA2AD

NOMESCO Finland

Thoracic spine CT examination

4.0

15.3

109

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

15.2

475

3237

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

15.2

374

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.5

15.2

404

RS121, ,

NOMESCO Finland

4.0

15.2

105

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

15.2

153

759

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

15.2

154

766

F20.5

ICD-10 Finland

Residual schizophrenia

4.4

15.2

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.3

15.1

110

480

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

6.3

15.0

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

15.0

1270

10258

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

15.0

407

2692

J96.0

ICD-10 Finland

Acute respiratory failure

2.8

14.9

263

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

14.8

627

4536

33098

ICD-8 Finland

Hereditary neuromuscular disorders, Alii definiti

31.8

14.8

X57

ICD-10 Finland

Unspecified privation

2.3

14.7

111

491

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

14.7

611

4404

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.7

14.7

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

14.7

181

964

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.4

14.7

393

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

14.6

200

1101

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

14.6

238

1381

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

14.6

131

622

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.4

14.6

418

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.3

14.6

108

474

G73.0*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic amyotrophy

+∞

14.6

K90

ICPC

Stroke/cerebrovascular accident

2.0

14.6

152

764

G73.7*M05.3

ICD-10 Finland

Rheumatoid myopathy

150.4

14.5

Z43.5

ICD-10 Finland

Attention to cystostomy

3.9

14.5

109

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

5.4

14.5

D07AC01

ATC

betamethasone; topical

1.3

14.4

1572

13113

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.1

14.4

N05CD08

ATC

midazolam; nasal, systemic

2.2

14.3

117

535

K92.0

ICD-10 Finland

Haematemesis

2.2

14.3

123

574

W06

ICD-10 Finland

Fall involving bed

3.3

14.3

157

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.3

14.3

162

G12.1

ICD-10 Finland

Other inherited spinal muscular atrophy

27.2

14.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

14.2

824

6285

M35.1

ICD-10 Finland

Other overlap syndromes

4.5

14.2

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.5

14.1

134

NH1AD

NOMESCO Finland

Ankle and foot CT

2.3

14.1

102

443

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

14.1

242

1425

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

14.1

113

513

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

14.1

182

984

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.3

14.0

R4110, ,

SPAT

1.6

14.0

359

2342

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

14.0

280

1719

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.9

14.0

222

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.7

13.9

261

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.5

13.9

360

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.3

13.9

160

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

13.9

1148

9226

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

13.9

708

5288

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

5.6

13.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

13.8

644

4740

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

13.8

212

1211

SPAT1281

SPAT

Other administrative function

1.6

13.8

334

2152

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.7

13.7

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.0

13.7

198

G20

ICD-10 Finland

Parkinson disease

1.9

13.7

159

831

E66.8

ICD-10 Finland

Other obesity

1.8

13.6

201

1133

N94

ICPC

Peripheral neuritis/neuropathy

6.5

13.6

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

13.6

244

1456

NJ3CM

NOMESCO Finland

Extensive MRI examination of extremities with 3 Tesla magnet

75.3

13.6

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

13.6

157

819

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

12.0

13.6

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

13.6

101

445

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.9

13.5

226

E000003, ,

ATC

1.8

13.5

184

1012

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.4

13.5

143

N05AD03

ATC

melperone; systemic

2.7

13.5

254

A10BH05

ATC

linagliptin; oral

1.7

13.5

244

1459

A10AE04

ATC

insulin glargine; parenteral

1.5

13.5

432

2959

N19

ICD-10 Finland

Unspecified kidney failure

1.9

13.5

177

963

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

13.4

150

773

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

13.4

168

901

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.4

1625

13712

N88

ICPC

Epilepsy

3.8

13.3

102

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

13.3

177

967

183

Kela drug reimbursment

Lamotrigin and topiramate

3.5

13.3

130

ZXD35

NOMESCO Finland

Usual procedure

2.0

13.2

151

784

NF3AA

NOMESCO Finland

Femur X-ray examination

2.2

13.2

106

482

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.5

13.2

327

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.0

13.2

144

737

C08CA05

ATC

nifedipine; systemic

1.6

13.1

285

1787

C07AB02

ATC

metoprolol; systemic

1.3

13.1

934

7343

A02BA02

ATC

ranitidine; systemic

1.3

13.1

861

6689

JN4BD

NOMESCO Finland

Extensive body CT

1.5

13.1

465

3251

RK110, ,

NOMESCO Finland

3.3

13.1

146

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

13.1

139

704

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

13.1

2246

19706

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

5.9

13.0

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

13.0

104

472

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

13.0

134

671

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.1

13.0

172

K92.1

ICD-10 Finland

Melaena

1.7

13.0

251

1528

K03.66

ICD-10 Finland

Tooth plaque

1.6

13.0

308

1974

XCK00

NOMESCO Finland

Perimetry

1.6

13.0

276

1723

P80

ICPC

Personality disorder

5.2

12.9

A07AA09

ATC

vancomycin; oral

2.6

12.9

283

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

12.9

160

854

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

12.9

790

6072

M54.1

ICD-10 Finland

Radiculopathy

1.9

12.9

174

955

ZXA00

NOMESCO Finland

Right side

1.3

12.9

1181

9611

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

5.6

12.9

R26.0

ICD-10 Finland

Ataxic gait

5.0

12.9

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.7

12.8

239

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

12.8

120

581

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

11.5

12.8

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

12.8

480

3394

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.1

12.7

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

12.7

162

873

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

10.5

12.7

S43.0

ICD-10 Finland

Dislocation of shoulder joint

1.9

12.7

168

917

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.2

12.7

100

452

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.0

12.7

175

SPAT1244

SPAT

Occupational therapy

3.0

12.6

191

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.3

12.6

P74

ICPC

Anxiety disorder/anxiety state

1.9

12.6

147

769

R03BB04

ATC

tiotropium bromide; inhalant

1.5

12.6

465

3275

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

12.6

164

890

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

12.6

169

926

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

12.6

423

2925

G71

ICD-10 Finland

Primary disorders of muscles

70.0

12.6

Z99.1

ICD-10 Finland

Dependence on respirator

70.0

12.6

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

6.0

12.6

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.0

12.6

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

5.5

12.6

RF420, ,

NOMESCO Finland

2.6

12.6

264

RF410, ,

NOMESCO Finland

2.8

12.6

230

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.3

12.6

145

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.7

12.6

247

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

12.5

820

6364

AA400

NOMESCO Finland

Electroconvulsive therapy

3.6

12.5

116

H49.4

ICD-10 Finland

Progressive external ophthalmoplegia

+∞

12.5

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

12.5

140

723

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

12.5

172

951

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

10.0

12.5

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

9.3

12.4

NK1AK

NOMESCO Finland

Spectroscopy of muscles

130.3

12.4

S51.0

ICD-10 Finland

Open wound of elbow

2.6

12.4

260

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

12.4

102

469

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.5

12.4

319

R35

ICD-10 Finland

Polyuria

1.6

12.4

305

1973

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

12.3

138

712

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

12.3

116

562

G44.2

ICD-10 Finland

Tension-type headache

1.4

12.3

510

3670

L16

ICPC

Ankle symptom/complaint

1.5

12.3

451

3172

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.3

12.3

400

H02AA02

ATC

fludrocortisone; oral

3.1

12.3

157

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.1

12.3

112

536

NBH10

NOMESCO Finland

Reduction of dislocation of humeroscapular joint, closed

3.6

12.3

108

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

11.6

12.3

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

5.4

12.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

12.3

351

SPAT1255

SPAT

Intravenous administration of medicine

1.6

12.3

303

1961

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

3.8

12.2

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

12.2

327

H50.52

ICD-10 Finland

Exophoria

3.1

12.2

168

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

12.2

331

2187

F48.0

ICD-10 Finland

Neurasthenia

9.0

12.2

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

3.5

12.2

118

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

12.2

103

479

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

12.2

313

2045

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.9

12.1

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

12.1

359

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

6.0

12.1

ZXY49

NOMESCO Finland

Other health care provider

4.8

12.1

29530

ICD-8 Finland

Schizophrenia, Paranoid type

4.8

12.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

12.1

229

1388

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.6

12.1

258

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.1

12.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

12.0

345

2309

S09.9

ICD-10 Finland

Unspecified injury of head

2.6

12.0

276

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

12.0

254

1583

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.9

12.0

186

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

12.0

386

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

3.9

12.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

12.0

1670

14277

C10AC01

ATC

colestyramine; oral

2.1

11.9

114

556

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.9

11.9

192

R5599

NOMESCO Finland

Other rehabilitation service

2.0

11.9

124

624

IFC04, ,

SPAT

13.4

11.9

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

11.9

970

7764

T90

ICPC

Diabetes non-insulin dependent

1.3

11.8

1059

8581

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

11.8

116

572

L04AA01

ATC

[U] ciclosporin

2.7

11.8

238

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

11.7

112

546

R06.4

ICD-10 Finland

Hyperventilation

2.6

11.7

250

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.1

11.7

110

533

NFM10

NOMESCO Finland

Fasciotomy of thigh

8.9

11.7

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.9

11.7

M48.9

ICD-10 Finland

Spondylopathy, unspecified

3.6

11.7

107

R07.3

ICD-10 Finland

Other chest pain

1.5

11.7

423

2969

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.3

11.7

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.9

11.7

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.4

11.7

347

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

3.7

11.6

30188

ICD-8 Finland

Personality disorders, Alia definita

4.0

11.6

L14

ICPC

Leg/thigh symptom/complaint

1.5

11.6

327

2179

E83.51

ICD-10 Finland

Hypocalcemia

3.6

11.6

103

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.0

11.6

163

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.1

11.5

153

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

11.5

438

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

11.5

835

6576

G61.9

ICD-10 Finland

Inflammatory polyneuropathy, unspecified

5.7

11.5

3592A

ICD-9 Finland

Muscular dystrophies and other myopathies, Myotonic disorders

+∞

11.5

G73.1

ICD-10 Finland

Lambert-Eaton syndrome

+∞

11.5

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.5

11.4

271

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

120.3

11.4

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

4.8

11.4

RS211, ,

NOMESCO Finland

4.8

11.4

ZYY01

NOMESCO Finland

Contact between professionals

4.8

11.4

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.4

2451

21906

R4120, ,

SPAT

3.1

11.4

149

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.2

11.4

408

S06.3

ICD-10 Finland

Focal brain injury

2.5

11.4

272

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

11.3

920

7353

N07

ICPC

Convulsion/seizure

5.4

11.3

J01CA08

ATC

pivmecillinam; oral

1.2

11.3

1507

12799

SPAT1312

SPAT

General health counselling

1.3

11.3

1296

10818

G04CA02

ATC

tamsulosin; oral

1.3

11.3

1137

9343

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.4

11.3

315

A10BA02

ATC

metformin; oral

1.3

11.3

1280

10673

G63.2

ICD-10 Finland

Diabetic polyneuropathy

3.9

11.3

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

11.2

843

6665

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

8.9

11.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

11.2

181

1050

M05BX04

ATC

denosumab; parenteral

1.6

11.2

256

1627

R5140, ,

SPAT

2.9

11.2

177

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

11.2

327

2197

L04AD01

ATC

ciclosporin; systemic

2.3

11.2

341

B01AC04

ATC

clopidogrel; oral

1.3

11.2

754

5873

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

11.2

1227

10189

F05.8

ICD-10 Finland

Other delirium

3.0

11.2

156

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

5.5

11.2

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

2.9

11.2

172

M35.7

ICD-10 Finland

Hypermobility syndrome

2.9

11.2

172

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

11.2

264

1692

L60.0

ICD-10 Finland

Ingrowing nail

1.7

11.0

190

1122

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.8

11.0

195

M05BA07

ATC

risedronic acid; oral

1.9

11.0

134

712

SAA04

NOMESCO Finland

Special examination of mouth

1.7

11.0

210

1275

SPAT1247

SPAT

Outpatient detoxication and monitoring

4.3

11.0

N06AB08

ATC

fluvoxamine; oral

2.0

11.0

112

560

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.8

11.0

157

879

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

2.6

10.9

230

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.2

10.9

127

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

10.9

153

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

10.9

308

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

10.9

114

576

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

5.4

10.9

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

5.4

10.9

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.4

10.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

10.8

118

604

I50.0

ICD-10 Finland

Congestive heart failure

1.5

10.8

358

2468

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

3.7

10.8

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

3.9

10.8

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

10.8

282

1849

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

10.8

215

1321

RS230, ,

NOMESCO Finland

3.6

10.8

A86

ICD-10 Finland

Unspecified viral encephalitis

4.0

10.7

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.7

10.7

215

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

17.8

10.7

N19

ICPC

Speech disorder

2.4

10.7

286

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

10.7

425

RK120, ,

NOMESCO Finland

4.7

10.7

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

10.7

270

1758

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.2

10.6

124

XA400

NOMESCO Finland

EEG

3.6

10.6

Y09

ICD-10 Finland

Assault by unspecified means

4.1

10.6

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

10.6

165

948

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.6

10.6

234

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

10.6

197

1190

SPAT1284

SPAT

Extensive health certificate

2.0

10.5

111

562

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

10.5

363

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

5.0

10.5

Z72.0

ICD-10 Finland

Tobacco use

2.0

10.5

104

515

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.3

10.5

332

Z00.8

ICD-10 Finland

Other general examinations

1.5

10.5

303

2032

Z29

ICPC

Social problem NOS

2.1

10.5

442

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

14.2

10.5

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

10.4

217

1348

M01AH02

ATC

rofecoxib; oral

1.4

10.4

533

3976

3590A

ICD-9 Finland

Muscular dystrophies and other myopathies, Congenital hereditary muscular dystrophy

+∞

10.4

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

2.8

10.4

179

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.1

10.4

131

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

10.4

1569

13483

A01AB09

ATC

miconazole; local oral

1.5

10.4

356

2472

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

10.4

111

565

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

5.4

10.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

10.4

295

1971

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.9

10.4

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.6

10.3

225

M60.0

ICD-10 Finland

Infective myositis

16.0

10.3

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.4

10.3

279

WX002

NOMESCO Finland

Sedation and analgesia

1.3

10.3

825

6578

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

10.6

10.3

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

18.8

10.2

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

10.2

137

752

S14.3

ICD-10 Finland

Injury of brachial plexus

4.5

10.2

S29

ICPC

Skin symptom/complaint other

1.3

10.2

778

6158

F61

ICD-10 Finland

Mixed and other personality disorders

4.7

10.2

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.0

10.2

143

D12

ICPC

Constipation

1.8

10.2

154

877

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

10.2

395

2809

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.0

10.2

101

501

J01CF05

ATC

flucloxacillin; systemic

1.6

10.2

243

1562

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

10.2

266

1746

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

3.7

10.1

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.6

10.1

216

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.1

841

6736

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.3

10.1

108

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.2

10.1

118

K56.0

ICD-10 Finland

Paralytic ileus

2.8

10.1

182

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

10.1

181

1082

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

11.3

10.0

M25.5

ICD-10 Finland

Pain in joint

1.2

10.0

1249

10503

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.3

10.0

ZXY60

NOMESCO Finland

2-person team, nurses

4.3

10.0

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.8

10.0

M41.4

ICD-10 Finland

Neuromuscular scoliosis

14.6

10.0

L18

ICPC

Muscle pain

1.8

10.0

159

920

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.6

10.0

206

SPAT1127

SPAT

Enema

2.9

9.9

156

F32.8

ICD-10 Finland

Other depressive episodes

2.4

9.9

272

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

9.9

115

603

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

9.8

259

1702

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

9.8

530

3987

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.5

9.8

249

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

9.8

116

612

318

Kela drug reimbursment

Teriparatide

3.6

9.8

N06AA04

ATC

clomipramine; systemic

2.3

9.8

311

I42.8

ICD-10 Finland

Other cardiomyopathies

4.0

9.8

29599

ICD-8 Finland

Schizophrenia, Unspecified type

3.8

9.7

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

9.7

282

1892

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

9.5

9.7

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.5

9.7

232

N06AX22

ATC

agomelatine; oral

2.2

9.7

382

R31

ICD-10 Finland

Unspecified haematuria

1.4

9.7

457

3363

OAB48, ,

SPAT

0.6

9.7

196

3082

D64.8

ICD-10 Finland

Other specified anaemias

2.1

9.6

390

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.6

9.6

204

R52.0

ICD-10 Finland

Acute pain

1.9

9.6

126

688

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.1

9.6

122

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

3.9

9.6

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.2

9.6

112

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.0

9.6

C09AA02

ATC

enalapril; systemic

1.3

9.6

871

7055

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.0

9.6

138

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

9.5

302

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

9.5

177

1069

R5130, ,

SPAT

4.6

9.5

A07AA02

ATC

nystatin; oral

1.6

9.5

246

1611

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

9.5

291

1976

N17

ICPC

Vertigo/dizziness

1.4

9.5

499

3738

RK220, ,

NOMESCO Finland

4.0

9.5

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

7.1

9.5

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.1

9.5

433

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.9

9.5

155

D07XC01

ATC

betamethasone; topical

1.4

9.4

500

3750

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.3

9.4

297

M04AA01

ATC

allopurinol; systemic

1.3

9.4

600

4629

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.8

9.4

148

854

F25

ICD-10 Finland

Schizoaffective disorders

7.5

9.4

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

3.9

9.4

G71.14

ICD-10 Finland

Paramyotonia congenita

+∞

9.4

73308, ,

ICD-8 Finland

+∞

9.4

NJ3BM

NOMESCO Finland

MRI examination of extremities with 3 Tesla magnet

+∞

9.4

J01MA14

ATC

moxifloxacin; systemic

1.4

9.4

366

2607

R63.1

ICD-10 Finland

Polydipsia

5.2

9.3

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.2

9.3

L73

ICPC

Fracture: tibia/fibula

2.5

9.3

237

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

8.0

9.3

S32.4

ICD-10 Finland

Fracture of acetabulum

3.1

9.3

119

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.7

9.3

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

9.3

318

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.5

9.3

245

1612

SPAT1210

SPAT

Application of cast or individual aid

1.7

9.3

161

955

Y94.8

ICD-10 Finland

Other leisure activity accident

1.9

9.3

114

610

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.4

9.3

244

E83.50

ICD-10 Finland

Hypercalcemia

2.5

9.3

238

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.5

9.2

232

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.9

9.2

118

639

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.1

9.2

371

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

9.2

187

1156

D01AC02

ATC

miconazole; topical

1.5

9.2

320

2230

F44.4

ICD-10 Finland

Dissociative motor disorders

13.7

9.2

P73

ICPC

Affective psychosis

4.2

9.2

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

9.1

662

5203

B01AF02

ATC

apixaban; oral

1.3

9.1

558

4280

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

9.1

460

J02AC01

ATC

fluconazole; systemic

1.2

9.1

1432

12328

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

9.1

325

2277

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

3.5

9.1

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.5

9.1

K29.2

ICD-10 Finland

Alcoholic gastritis

4.8

9.1

RK320, ,

NOMESCO Finland

2.8

9.0

159

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.0

9.0

468

G61.0

ICD-10 Finland

Guillain-Barré syndrome

4.0

9.0

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.7

9.0

176

Y34

ICD-10 Finland

Unspecified event, undetermined intent

3.4

9.0

H50.31

ICD-10 Finland

Intermittent exotropia

3.2

9.0

111

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.4

9.0

247

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

3.3

9.0

RF432, ,

NOMESCO Finland

36.7

9.0

NCM10

NOMESCO Finland

Fasciotomy of forearm

9.0

EBB10

NOMESCO Finland

Insertion of dental implant

2.5

9.0

223

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

7.0

9.0

RS314, ,

NOMESCO Finland

7.0

9.0

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

7.0

9.0

SPAT1325

SPAT

Vaccination

1.2

9.0

1449

12499

WYA20

NOMESCO Finland

Home visit

2.1

9.0

408

A12AA04

ATC

calcium carbonate; oral

2.2

9.0

310

NF1DA

NOMESCO Finland

X-ray of hips

2.0

9.0

476

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

3.7

9.0

S76

ICPC

Skin infection other

1.6

9.0

214

1376

A07DA03

ATC

loperamide; oral

1.7

9.0

142

821

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

9.0

173

1056

G24.0

ICD-10 Finland

Drug-induced dystonia

18.6

8.9

M72.9

ICD-10 Finland

Fibroblastic disorder, unspecified

24.0

8.9

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

8.9

167

1012

R06AE07

ATC

cetirizine; oral

1.2

8.9

1765

15534

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

8.9

136

779

U05

ICPC

Urination problems other

1.6

8.9

212

1364

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

8.9

185

1152

K11.2

ICD-10 Finland

Sialoadenitis

1.8

8.9

123

684

D07AB08

ATC

desonide; topical

1.4

8.9

415

3051

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

8.8

213

1373

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

8.8

789

6370

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

7.9

8.8

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.1

8.8

411

N81

ICPC

Injury nervous system other

4.9

8.8

S20.2

ICD-10 Finland

Contusion of thorax

1.6

8.8

210

1350

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

8.8

445

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

6.8

8.8

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

8.6

8.8

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

3.5

8.8

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

4.0

8.8

R51

ICD-10 Finland

Headache

1.6

8.8

182

1132

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.3

8.7

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.1

8.7

366

SPAT1138

SPAT

Guidance concerning bowel function

2.2

8.7

314

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

8.7

340

R81

ICPC

Pneumonia

1.7

8.7

145

851

N05AF01

ATC

flupentixol; systemic

2.2

8.7

308

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

8.7

169

1034

M54

ICD-10 Finland

Dorsalgia

1.4

8.7

449

3355

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

14.0

8.7

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

4.2

8.6

G04BD09

ATC

trospium; oral

1.9

8.6

105

560

ECB00

NOMESCO Finland

Suture of gingiva

1.7

8.6

143

838

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.6

1897

16843

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

4.8

8.6

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.0

8.6

457

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

16.3

8.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

8.5

141

826

WX890

NOMESCO Finland

Intesive care monitoring

2.9

8.5

131

ZXE22

NOMESCO Finland

Procedure duration at least 4 but less than 5 hours

6.9

8.5

WX320

NOMESCO Finland

Spinalanesthesy

1.2

8.5

1001

8347

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

8.5

194

1236

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.2

8.5

305

R4180

NOMESCO Finland

Podiatric therapy

2.4

8.5

242

Z82.6

ICD-10 Finland

Family history of arthritis and other diseases of the musculoskeletal system and connective tissue

20.0

8.5

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.7

8.5

139

813

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

8.5

158

957

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

8.4

266

1818

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.0

8.4

121

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.9

8.4

515

A97

ICPC

No disease

1.3

8.4

705

5643

G04BD11

ATC

fesoterodine; oral

1.8

8.4

120

673

W17

ICD-10 Finland

Other fall from one level to another

1.7

8.4

164

1004

R15

ICD-10 Finland

Faecal incontinence

1.8

8.4

114

630

H53.3

ICD-10 Finland

Other disorders of binocular vision

3.9

8.4

F21, ,

ICPC

2.5

8.4

201

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

12.8

8.4

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

8.4

346

N05BB01

ATC

hydroxyzine; systemic

1.5

8.4

236

1577

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

8.4

223

1472

G71.2

ICD-10 Finland

Congenital myopathies

+∞

8.3

3598X

ICD-9 Finland

Muscular dystrophies and other myopathies, Other myopathies

+∞

8.3

G71.21

ICD-10 Finland

Fibre type disproportion

+∞

8.3

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.0

8.3

122

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.9

8.3

104

560

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.7

8.3

155

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

2.6

8.3

178

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

8.3

299

2099

D38.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thymus

10.7

8.3

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

8.3

374

F06.7

ICD-10 Finland

Mild cognitive disorder

1.8

8.3

128

736

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

8.2

2270

20533

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.8

8.2

109

598

N03AX23

ATC

brivaracetam; systemic

7.1

8.2

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.5

8.2

203

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.3

8.2

271

NFA20

NOMESCO Finland

Exploration of hip joint or femur

14.5

8.2

A03FA02

ATC

cisapride; oral, rectal

1.4

8.2

305

2154

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

4.2

8.2

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

8.2

162

997

ELA30

NOMESCO Finland

Biopsy of salivary gland

6.5

8.2

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

8.2

310

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.8

8.1

140

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.6

8.1

203

1320

ZXA10

NOMESCO Finland

Bilateral

1.3

8.1

767

6232

Z10.0

ICD-10 Finland

Occupational health examination

0.6

8.1

102

1811

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

3.6

8.1

RS110, ,

NOMESCO Finland

4.5

8.1

R26

ICD-10 Finland

Abnormalities of gait and mobility

4.7

8.1

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

4.7

8.1

Z28

ICPC

Limited function/disability (Z)

3.1

8.1

103

G61.8

ICD-10 Finland

Other inflammatory polyneuropathies

8.1

NFQ20

NOMESCO Finland

Amputation of femur

2.7

8.1

152

WX213

NOMESCO Finland

Lower leg blockade

2.7

8.1

152

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

17.2

8.1

GBB00

NOMESCO Finland

Tracheostomy

2.4

8.1

223

R40.0

ICD-10 Finland

Somnolence

4.0

8.1

G41.0

ICD-10 Finland

Grand mal status epilepticus

6.8

8.0

S72.4

ICD-10 Finland

Fracture of lower end of femur

2.7

8.0

158

ZZH40

NOMESCO Finland

Substitute of bone

2.7

8.0

158

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.6

8.0

158

971

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

8.0

172

1080

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.7

8.0

147

A05

ICPC

Feeling ill

1.5

8.0

204

1335

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.0

712

5746

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.8

8.0

106

583

RS224, ,

NOMESCO Finland

3.5

8.0

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

7.9

429

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

1.8

7.9

116

658

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

7.9

213

1411

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

3.9

7.9

CE2W4

NOMESCO Finland

Eye movement mapping

6.6

7.9

R03AC13

ATC

formoterol; inhalant

1.6

7.9

195

1267

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

7.7

7.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

7.9

1037

8748

N06AA22, ,

ATC

2.9

7.8

121

E23.00

ICD-10 Finland

Panhypopituitarism

3.6

7.8

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

7.8

158

977

B37.0

ICD-10 Finland

Candidal stomatitis

2.5

7.8

178

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.4

7.8

208

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

8.4

7.8

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

2.9

7.8

116

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.8

3042

28280

FM2CE, ,

NOMESCO Finland

3.8

7.8

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

3.8

7.8

A11CC03

ATC

alfacalcidol; systemic

1.9

7.8

100

544

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

2.7

7.8

155

L13.9

ICD-10 Finland

Bullous disorder, unspecified

3.3

7.8

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

7.8

145

879

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.2

7.7

278

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.5

7.7

179

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.0

7.7

364

30041

ICD-8 Finland

Neuroses, Depressiva

2.3

7.7

259

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.6

7.7

186

1201

XA100

NOMESCO Finland

Tensilon test

45.0

7.7

F32

ICD-10 Finland

Depressive episode

1.6

7.7

169

1067

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

15.0

7.7

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.0

7.7

419

F30.0

ICD-10 Finland

Hypomania

6.4

7.7

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

3.9

7.7

R03BA05

ATC

fluticasone; inhalant

1.3

7.7

702

5679

M01AX17

ATC

nimesulide; oral

1.2

7.7

996

8385

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.6

7.7

173

1100

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

3.4

7.7

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

7.6

349

2556

F21

ICD-10 Finland

Schizotypal disorder

3.3

7.6

ZXA05

NOMESCO Finland

Left side

1.2

7.6

1051

8902

P06

ICPC

Sleep disturbance

1.4

7.6

413

3109

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

3.7

7.6

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.7

7.6

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

7.6

142

861

SBB10

NOMESCO Finland

Dental impressions

1.5

7.6

234

1593

S14

ICPC

Burn/scald

1.7

7.6

124

725

G11.8

ICD-10 Finland

Other hereditary ataxias

18.4

7.6

R80

ICD-10 Finland

Isolated proteinuria

2.7

7.6

140

S01

ICD-10 Finland

Open wound of head

2.2

7.6

261

H50.8

ICD-10 Finland

Other specified strabismus

8.0

7.6

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.0

7.6

394

M54.3

ICD-10 Finland

Sciatica

1.5

7.6

225

1521

H49.8

ICD-10 Finland

Other paralytic strabismus

25.0

7.6

M02AA10

ATC

ketoprofen; topical

1.3

7.6

633

5065

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

7.6

144

878

R49.08

ICD-10 Finland

Other specified dysphonia

2.0

7.6

422

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

7.5

862

7157

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

7.5

153

948

K70.4

ICD-10 Finland

Alcoholic hepatic failure

3.5

7.5

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

6.1

7.5

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

7.5

275

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.2

7.5

288

SPAT1042

SPAT

Guidance concerning balance maintenance

3.2

7.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

7.5

380

2831

H05AA02

ATC

teriparatide; parenteral

3.3

7.5

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

7.5

458

P27

ICPC

Fear of mental disorder

2.4

7.5

206

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.0

7.5

108

Z01.2

ICD-10 Finland

Dental examination

1.2

7.5

1761

15678

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

7.5

142

865

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.4

7.5

200

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

7.5

193

1266

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.8

7.5

114

654

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

7.5

365

2704

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.2

7.4

289

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

3.1

7.4

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.8

7.4

125

R25.3

ICD-10 Finland

Fasciculation

3.5

7.4

Z11

ICPC

Compliance/being ill problem

2.7

7.4

142

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.5

7.4

177

ZYD04

NOMESCO Finland

Emergency outreach service, another specialty

13.4

7.4

D15.0

ICD-10 Finland

Benign neoplasm: Thymus

13.4

7.4

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

13.4

7.4

F60.8

ICD-10 Finland

Other specific personality disorders

3.3

7.4

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.0

7.4

364

S11

ICPC

Skin infection post-traumatic

2.3

7.4

239

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.3

1050

8925

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.0

7.3

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

7.3

123

725

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.6

7.3

160

R03DA04

ATC

theophylline; systemic, rectal

1.5

7.3

226

1540

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.1

7.3

311

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

7.3

174

1121

H02AB13

ATC

deflazacort; oral

+∞

7.3

3589X

ICD-9 Finland

Myoneural disorders, unspecified

+∞

7.3

G71.10

ICD-10 Finland

Myotonia drug-induced

+∞

7.3

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

7.3

136

825

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

10.9

7.3

R95

ICPC

Chron obstructive pulmonary disease

1.7

7.3

118

689

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

7.3

165

1051

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

4.1

7.3

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.2

7.2

S80.0

ICD-10 Finland

Contusion of knee

1.4

7.2

257

1800

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.2

1722

15334

L03

ICD-10 Finland

Cellulitis

2.6

7.2

161

XA421

NOMESCO Finland

Nocturnal polygraphy

3.8

7.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

7.2

427

3257

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

3.2

7.2

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

3.2

7.2

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

2.5

7.2

173

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

7.2

211

1422

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

2.1

7.2

326

S82.1

ICD-10 Finland

Fracture of upper end of tibia

2.0

7.2

360

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

2.9

7.2

116

G83.4

ICD-10 Finland

Cauda equina syndrome

3.7

7.2

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

7.2

1163

10005

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

4.5

7.2

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.7

7.2

133

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.2

1562

13804

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

3.9

7.1

RS122, ,

NOMESCO Finland

3.9

7.1

R03BA08

ATC

ciclesonide; inhalant

1.4

7.1

309

2243

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.1

642

5182

Z93.0

ICD-10 Finland

Tracheostomy status

30.0

7.1

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.7

7.1

122

723

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.1

715

5846

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

7.1

389

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.9

7.1

424

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

7.1

355

Z04

ICD-10 Finland

Examination and observation for other reasons

2.1

7.1

308

K86.3

ICD-10 Finland

Pseudocyst of pancreas

3.4

7.1

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.5

7.1

163

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.5

7.1

188

1242

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.0

7.0

370

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

5.6

7.0

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

1.8

7.0

533

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.0

7.0

384

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

8.8

7.0

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

8.8

7.0

F83

ICD-10 Finland

Mixed specific developmental disorders

3.6

7.0

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

4.2

7.0

P98

ICPC

Psychosis NOS/other

3.1

7.0

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

7.0

188

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.5

7.0

158

D07AA02

ATC

hydrocortisone; topical

1.3

7.0

516

4062

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

7.0

N05AX13

ATC

paliperidone; systemic

3.5

7.0

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.6

7.0

166

1070

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

7.0

182

1198

M54.8

ICD-10 Finland

Other dorsalgia

1.6

7.0

152

960

T74.1

ICD-10 Finland

Physical abuse

2.1

7.0

284

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.3

7.0

207

L30.3

ICD-10 Finland

Infective dermatitis

1.7

7.0

126

759

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

6.9

233

1615

B80

ICPC

Iron deficiency anaemia

1.8

6.9

492

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.1

6.9

278

205

Kela drug reimbursment

Chronic hypertension

1.2

6.9

1227

10640

IGY02, ,

SPAT

2.6

6.9

153

NG1AD

NOMESCO Finland

Knee CT examination

2.1

6.9

298

D11

ICPC

Diarrhoea

1.3

6.9

403

3069

NHQ40

NOMESCO Finland

Amputation of toe

2.0

6.9

359

AA3AD

NOMESCO Finland

CT of face

2.7

6.9

130

Z02.4

ICD-10 Finland

Examination for driving licence

0.8

6.9

873

10323

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.7

6.9

115

678

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.7

6.9

116

686

M02AA07

ATC

piroxicam; topical

1.2

6.9

1523

13471

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.7

6.8

117

694

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.8

698

5719

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.9

6.8

473

J46

ICD-10 Finland

Status asthmaticus

1.7

6.8

108

627

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.1

6.8

313

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.3

6.8

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.0

6.8

354

V03AA02, ,

ATC

8.3

6.8

E51.2

ICD-10 Finland

Wernicke encephalopathy

8.3

6.8

WYA30, ,

SPAT

2.7

6.8

131

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

4.1

6.8

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.3

6.8

203

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

3.8

6.8

R04

ICPC

Breathing problem other

1.6

6.8

137

849

PD5AD

NOMESCO Finland

CT of aorta

1.8

6.8

496

TNX30

NOMESCO Finland

Soft bandage, unspecified region

2.2

6.8

261

N05AA03

ATC

promazine; systemic

5.6

6.7

J86.9

ICD-10 Finland

Pyothorax without fistula

2.5

6.7

161

Z51.5

ICD-10 Finland

Palliative care

1.4

6.7

334

2481

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

6.7

165

1071

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.3

6.7

204

S82.0

ICD-10 Finland

Fracture of patella

2.0

6.7

356

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.9

6.7

419

A02BA03

ATC

famotidine; systemic

1.6

6.7

150

954

N05AC01

ATC

periciazine; systemic

3.4

6.7

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.4

6.7

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.7

428

3305

G37.2

ICD-10 Finland

Central pontine myelinolysis

22.5

6.7

XG416

NOMESCO Finland

Measurement of maximal airway pressure

22.5

6.7

AA1AA

NOMESCO Finland

Head X-ray examination

2.5

6.7

156

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

6.7

161

1042

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

6.7

171

1122

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

3.7

6.6

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

2.8

6.6

116

WX212

NOMESCO Finland

Femoral plexus blockade

1.8

6.6

551

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.7

6.6

114

678

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

2.2

6.6

231

I50

ICD-10 Finland

Heart failure

1.6

6.6

132

816

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

6.6

133

824

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

3.0

6.6

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.0

6.6

H02BX01

ATC

methylprednisolone, combinations; systemic

1.5

6.6

204

1392

N07XX02

ATC

riluzole; oral

5.5

6.6

R39.1

ICD-10 Finland

Other difficulties with micturition

1.6

6.6

128

786

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

6.6

215

1484

QBA10

NOMESCO Finland

Incision of skin of trunk

2.3

6.6

200

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

3.2

6.6

J45.8

ICD-10 Finland

Mixed asthma

1.7

6.6

119

718

-1, ,

NOMESCO Finland

1.2

6.5

1257

10971

K28

ICPC

Limited function/disability (K)

1.8

6.5

531

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.3

6.5

F45.0

ICD-10 Finland

Somatization disorder

3.3

6.5

A14AB01

ATC

nandrolone; parenteral

4.2

6.5

C08CA02

ATC

felodipine; oral

1.3

6.5

398

3051

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.5

6.5

172

1135

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.8

6.5

524

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.5

215

1486

F10.04

ICD-10 Finland

Alcohol-related acute intoxication with hallucinations

10.0

6.5

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

6.5

137

858

F41.00

ICD-10 Finland

Moderate panic disorder

2.2

6.5

239

D17

ICPC

Incontinence of bowel

2.4

6.5

176

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.5

6.5

146

TAB20

NOMESCO Finland

Epidural puncture

2.5

6.5

146

Z82.0

ICD-10 Finland

Family history of epilepsy and other diseases of the nervous system

6.8

6.5

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

6.8

6.5

S22

ICPC

Nail symptom/complaint

1.4

6.5

237

1670

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.5

6.5

158

TGC00

NOMESCO Finland

Bronchial lavation

1.8

6.5

562

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.7

6.5

110

652

G43.3

ICD-10 Finland

Complicated migraine

2.3

6.5

214

127

Kela drug reimbursment

Transplant complication

2.1

6.5

286

P05

ICPC

Senility, feeling/behaving old

2.9

6.5

101

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

6.2

6.5

RS140, ,

NOMESCO Finland

6.2

6.5

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

6.2

6.5

A01AB04

ATC

amphotericin B; local oral

1.5

6.4

180

1203

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

6.4

648

5299

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

2.6

6.4

135

K56.2

ICD-10 Finland

Volvulus

2.6

6.4

135

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

6.4

556

N06BA07

ATC

modafinil; oral

3.9

6.4

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

293

216

14.31

317.44

1.8

1.4

8.81

6.41

u/l

1.14

239

183

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1293

1454

11.48

307.65

3.1

2.2

1791.27

373.11

ug/l

9.69

1216

1370

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3320

13053

5.22

307.65

4.8

2.1

1445.36

174.97

u/l

38.73

3172

12212

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

376

201

20.08

307.65

1.2

1.1

12.67

0.11

nmol/l

6.62

177

(3023368) Bacteria identified in Blood by Culture

2360

12278

2.68

256.38

5.4

4.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3414

21659

2.66

240.40

9.7

6.9

1.20

1.21

mmol/l

6.95

2905

18399

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1404

5849

2.91

231.12

6.0

6.1

1.07

1.04

mmol/l

1.84

1290

5422

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3161

19612

2.54

228.48

9.1

6.2

1.20

1.21

mmol/l

8.76

2938

17866

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1588

7124

2.76

226.49

3.6

3.5

0.80

0.82

mmol/l

3.44

1460

6642

(3023183) Ammonium ion [Moles/volume] in Plasma

462

929

5.36

218.89

3.1

2.9

30.44

35.62

umol/l

3.44

413

834

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

143

24.07

200.18

1.1

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1534

7260

2.57

191.58

2.1

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

818

2782

3.30

188.67

5.1

4.0

1.64

1.83

mmol/l

0.70

652

2042

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

843

2920

3.25

188.64

5.1

4.1

5.23

5.16

kpa

1.51

805

2755

(3009343) pH of Capillary blood

834

2882

3.25

187.28

5.1

4.1

7.41

0.10

128

336

(3024561) Albumin [Mass/volume] in Serum or Plasma

2915

18756

2.25

174.96

5.5

4.9

33.70

35.25

g/l

32.05

2670

17393

(3013826) Glucose [Moles/volume] in Serum or Plasma

3550

25275

2.26

159.09

7.8

4.8

6.78

6.79

mmol/l

0.09

3411

23750

(3014111) Lactate [Moles/volume] in Serum or Plasma

943

3916

2.72

149.62

8.9

7.1

1.50

1.36

mmol/l

3.18

913

3807

(40760892) CBC W Ordered Manual Differential panel - Blood

2931

19704

2.11

147.22

8.8

6.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3032

20742

2.10

144.07

17.2

16.7

1.26

1.31

inr

2.43

842

5941

(3019309) Folate [Moles/volume] in Red Blood Cells

1584

8477

2.25

143.08

2.0

1.8

1204.15

1163.05

nmol/l

0.89

1186

6360

(3006315) Basophils [#/volume] in Blood

3053

21004

2.09

142.04

8.5

5.8

0.04

e9/l

2.23

2704

18054

(3001604) Monocytes [#/volume] in Blood

3046

20953

2.09

141.58

8.5

5.8

0.62

0.60

e9/l

3.21

2702

18008

(3013115) Eosinophils [#/volume] in Blood

3126

21713

2.09

141.48

8.9

6.1

0.18

0.20

e9/l

3.18

2766

18925

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3167

22181

2.08

139.15

6.8

6.3

11.75

11.99

umol/l

0.36

2971

21048

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2557

16583

2.06

138.59

5.6

3.8

79.84

81.53

ng/l

0.02

2122

11890

(3020779) Urea [Moles/volume] in Serum or Plasma

942

4106

2.58

134.36

7.6

11.46

10.24

mmol/l

3.96

887

3899

(3019198) Lymphocytes [#/volume] in Blood

3083

21541

2.05

134.29

8.6

5.9

1.81

1.91

e9/l

1.38

2758

18932

(3019069) Monocytes/100 leukocytes in Blood

2898

19837

2.03

133.28

9.3

6.4

8.67

8.74

0.53

2732

18524

(3006504) Eosinophils/100 leukocytes in Blood

2885

19721

2.03

133.14

8.8

6.1

2.60

2.87

8.59

2716

18382

(3022313) Gas panel - Capillary blood

603

2095

3.12

131.87

5.5

4.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

550

1814

3.27

131.24

5.9

4.4

24.70

24.80

mmol/l

0.29

509

1670

(3026008) Bacteria identified in Urine by Culture

2126

13079

2.05

131.20

3.8

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2660

17731

2.02

131.03

2.3

2.0

92.89

94.59

pmol/l

0.96

1511

9293

(3031040) Bacteria [#/volume] in Urine by Automated count

3686

27703

2.12

128.87

6.3

4.6

871.49

1935.07

e6/l

0.99

429

(3022096) Basophils/100 leukocytes in Blood

2803

19130

2.00

128.01

8.8

6.1

0.62

0.67

4.97

2633

17811

(3002030) Lymphocytes/100 leukocytes in Blood

2929

20350

2.00

126.48

8.9

6.2

25.37

27.40

18.06

2755

19044

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

188

8.75

125.67

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

2880

20049

1.97

121.84

8.7

6.0

59.53

57.51

14.68

2713

18745

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4120

32614

2.24

121.71

9.8

7.6

81.10

79.77

u/l

0.93

3894

30680

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2092

13063

2.00

121.36

3.5

3.1

1966.89

1634.47

ng/l

1.50

1777

11237

(3013650) Neutrophils [#/volume] in Blood by Automated count

3298

24284

1.97

115.60

12.2

9.0

4.55

4.17

e9/l

12.37

2943

21077

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1833

11087

2.01

114.97

2.6

2.3

3.13

3.00

mg/l

1.48

1521

9458

(3012544) pH of Venous blood

951

4449

2.39

114.87

5.7

4.1

7.38

7.37

0.37

(3021447) Carbon dioxide [Partial pressure] in Venous blood

927

4288

2.41

114.85

5.7

4.1

5.92

5.84

kpa

1.47

890

4155

(3002032) Base excess in Venous blood by calculation

923

4279

2.40

113.69

5.7

4.1

1.93

1.99

mmol/l

0.18

789

3609

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2099

13369

1.95

112.78

3.2

2.6

59.31

65.84

u/l

0.53

1931

12348

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1046

5187

2.27

109.85

9.2

7.2

5.18

5.09

kpa

1.74

1002

4926

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

665

2686

2.69

109.26

1.9

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1044

5186

2.27

109.11

9.3

7.2

11.41

12.26

kpa

6.17

998

4924

(3003396) Base excess in Arterial blood by calculation

1040

5173

2.26

108.26

9.3

7.2

1.50

1.10

mmol/l

2.00

851

4062

(3037522) Nuclear Ab [Titer] in Serum

1047

5225

2.25

108.11

1.4

1.3

648.39

515.52

titre

1.30

267

1090

(3037467) Urinalysis macro (dipstick) panel - Urine

3703

28855

1.97

103.88

5.8

4.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1678

10123

1.97

103.83

1.8

1.6

18.64

20.23

nmol/l

4.14

1422

8642

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2473

16983

1.86

102.46

2.8

2.3

74.67

77.74

nmol/l

4.69

2169

15139

(3022948) Iron [Moles/volume] in Serum or Plasma

1264

6925

2.09

102.21

2.7

2.5

11.56

12.83

umol/l

8.00

1135

6444

(3000991) Gas panel - Venous blood

819

3785

2.38

100.65

11.2

8.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

479

1700

3.00

99.97

2.2

1.8

—

(3016502) Oxygen saturation in Arterial blood

943

4655

2.25

99.17

9.7

7.6

94.89

95.59

1.98

907

4470

(3036481) Cortisol [Moles/volume] in Serum or Plasma

800

3717

2.36

96.87

2.3

2.2

359.42

370.87

nmol/l

0.82

728

3398

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

498

1853

2.86

95.25

2.3

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

851

4104

2.28

94.27

2.3

0.20

0.21

g/l

4.39

760

3824

(3018418) pH of Serum or Plasma

1965

12804

1.86

93.95

5.1

4.0

7.40

0.23

415

2454

(3020630) Protein [Mass/volume] in Serum or Plasma

789

3717

2.32

92.21

2.0

2.6

64.90

66.29

g/l

4.83

699

3367

(3015377) Calcium [Moles/volume] in Serum or Plasma

2145

14456

1.82

91.17

3.1

3.4

2.33

2.35

mmol/l

7.53

1811

12629

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1161

6429

2.04

89.67

2.7

2.5

2.25

2.30

g/l

1.63

1045

5939

(3024354) Oxygen [Partial pressure] in Venous blood

758

3550

2.33

89.65

5.3

3.5

4.67

4.58

kpa

0.45

718

3427

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

330

5.48

89.26

2.0

1.4

1.44

1.32

promille

0.39

149

258

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

702

3188

2.39

89.06

1.9

1.6

—

(3019225) pH of Specimen

859

4293

2.20

86.65

5.8

4.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

974

5112

2.11

86.65

3.0

4.3

262.99

245.85

u/l

2.38

897

4812

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

908

4644

2.16

86.36

2.3

1.8

1.73

1.50

10.95

764

4072

(3007853) Bacteria identified in Skin by Aerobe culture

959

5014

2.12

86.13

2.3

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1097

6034

2.03

85.89

2.8

2.6

20.82

22.57

3.68

917

5129

(3005719) IgG [Mass/volume] in Serum or Plasma

682

3124

2.36

84.60

2.6

2.7

10.24

10.50

g/l

0.79

618

2839

(3004588) Protein electrophoresis panel - Serum or Plasma

672

3071

2.36

83.76

1.9

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

237

602

4.08

82.97

5.7

4.8

353.21

353.85

umol/l

0.02

205

525

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

539

2240

2.57

82.57

6.5

4.4

23.80

24.15

mmol/l

1.59

517

2190

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

952

5042

2.09

82.27

2.0

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

473

1848

2.71

82.05

2.2

2.0

2.60

2.17

ug/l

0.33

384

1626

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

342

1124

3.19

81.12

2.5

1.5

0.22

0.24

g/l

2.88

331

1060

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

348

1163

3.13

80.23

2.5

1.5

1.14

1.18

g/l

1.86

334

1096

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

944

5042

2.06

79.49

2.0

1.8

—

(3019060) Gas panel - Arterial blood

654

3019

2.33

79.42

6.2

4.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2420

17366

1.73

79.35

3.3

2.8

165.49

140.85

ug/l

3.52

2178

15955

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

585

2607

2.40

76.86

1.7

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

306

1000

3.19

73.17

1.5

1.4

565.11

540.79

mg/l

0.20

292

940

(3026782) Osmolality of Urine

1417

8888

1.81

72.82

3.6

2.9

518.89

546.47

mosm/kgh2o

5.25

1268

7621

(3013707) Erythrocyte sedimentation rate by Westergren method

3757

30888

1.77

71.51

5.4

4.1

15.03

12.71

mm/h

13.67

3439

28466

(3002582) Erythrocytes [#/volume] in Urine

1928

13322

1.71

69.98

4.3

3.3

43.88

97.82

e6/l

3.27

1591

10263

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

278

882

3.27

69.77

1.4

3.99

3.80

mmol/l

1.68

258

822

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

265

817

3.36

69.66

1.4

1.2

2.10

11.36

u/ml

—

(3027945) Reticulocytes/100 erythrocytes in Blood

935

5197

1.97

69.52

2.4

2.6

1.85

1.77

1.31

777

4574

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3358

26883

1.70

69.07

4.9

3.1

65.30

51.45

u/l

7.25

3103

24899

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

331

1172

2.95

68.81

2.4

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

803

4268

2.04

67.60

10.8

8.0

121.79

121.54

g/l

0.13

784

4145

(3018095) Leukocytes [#/volume] in Urine

2135

15275

1.67

67.20

5.0

3.8

94.73

104.09

e6/l

0.24

1665

10964

(3000850) Epithelial cells [#/volume] in Urine

1438

9279

1.76

65.98

3.4

2.6

5.58

5.08

e6/l

0.78

1336

8305

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

30.96

65.59

1.0

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

1777

12177

1.70

65.46

4.3

3.2

0.57

0.45

e6/l

0.98

1459

9306

(1616796) Gas panel - Central venous blood

296

1016

3.03

64.98

4.2

3.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

758

4017

2.04

64.09

2.8

2.4

13.23

7.48

ug/l

3.91

597

3513

(3015171) Extractable nuclear Ab [Units/volume] in Serum

366

1424

2.69

63.62

1.3

1.2

1.50

0.97

u/ml

0.16

136

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1913

13443

1.67

63.58

4.2

3.3

49.44

36.07

u/l

6.23

1787

12736

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

349

1333

2.73

62.88

1.4

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

100

8.31

62.43

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

100

8.31

62.43

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

100

8.31

62.43

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

100

8.31

62.43

1.2

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

576

2776

2.21

62.35

9.2

7.7

24.77

24.89

mmol/l

0.26

567

2754

(36304419) Bacteria [Presence] in Urine

1717

11807

1.68

61.56

4.2

3.2

—

(3023520) Reticulocytes [#/volume] in Blood

732

3886

2.03

61.41

2.4

2.6

67.87

68.57

e9/l

0.21

546

2941

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3720

31077

1.68

60.35

4.6

3.9

15.01

14.87

pmol/l

2.39

3365

28053

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

469

2105

2.35

60.08

1.7

1.66

1.54

g/l

1.64

389

1798

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

245

797

3.18

58.92

1.3

1.2

12.89

5.83

u/ml

0.32

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

507

2375

2.26

58.68

11.1

9.4

24.65

24.30

mmol/l

1.24

482

2293

(3028026) IgM [Mass/volume] in Serum or Plasma

518

2454

2.23

58.33

1.8

1.9

1.12

1.40

g/l

3.23

467

2220

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

113

211

5.45

57.55

13.1

13.2

9667.94

821.31

nmol/l

0.49

108

202

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

285

1033

2.86

56.63

1.4

1.2

36.59

37.24

u/ml

0.02

(3003181) Sodium [Moles/volume] in Urine

240

798

3.10

55.60

1.5

1.4

57.21

64.19

mmol/l

1.63

176

642

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1106

6918

1.76

55.10

2.4

2.2

29.82

30.06

0.66

1065

6701

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1374

9124

1.69

55.07

1.9

1.8

1.58

1.29

mg/l

1.83

1056

7007

(3014271) Vancomycin [Susceptibility]

118

239

5.03

54.86

4.0

3.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

407

1787

2.39

54.67

1.3

1.5

17.02

17.63

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

271

975

2.88

54.58

1.4

1.2

6.33

7.58

u/ml

0.13

162

(3012501) Base excess in Blood by calculation

277

1009

2.84

54.52

5.4

4.6

2.55

2.64

mmol/l

0.24

203

694

(3013290) Carbon dioxide [Partial pressure] in Blood

277

1010

2.84

54.42

5.4

4.6

5.00

5.04

kpa

0.33

268

990

(3027315) Oxygen [Partial pressure] in Blood

278

1016

2.83

54.38

5.4

4.6

8.58

8.45

kpa

0.53

269

995

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

268

963

2.88

54.09

1.4

1.2

4.77

3.20

u/ml

0.44

(3044640) Blood type and Crossmatch panel - Blood

1874

13504

1.60

54.00

3.1

2.5

—

(3028707) Methadone [Presence] in Urine by Screen method

186

540

3.53

53.63

3.4

3.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

377

4.07

53.22

1.6

1.5

—

(3013512) EKG study

1760

12563

1.60

52.38

4.9

4.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

182

5.58

52.37

2.1

2.3

161.31

111.93

umol/l

0.57

103

(3014576) Chloride [Moles/volume] in Serum or Plasma

934

5663

1.79

51.39

10.6

6.9

104.00

104.38

mmol/l

1.29

934

5658

(3010421) pH of Blood

301

1181

2.64

51.29

5.3

4.5

7.42

0.01

273

1067

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

622

3314

2.00

51.10

4.1

4.0

93.95

92.83

ng/l

0.09

524

2839

(3044290) Cell count panel - Cerebral spinal fluid

237

821

2.98

51.09

1.7

1.5

—

(3042936) Bacteria identified in Isolate by Culture

993

6153

1.76

50.63

2.6

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

262

967

2.80

50.28

3.4

2.5

16.50

16.13

0.72

157

496

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

247

884

2.88

50.20

1.7

1.5

12.97

22.85

e6/l

0.61

200

682

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

247

885

2.88

50.09

1.7

1.6

1479.36

1171.82

e6/l

0.16

207

725

(3008152) Bicarbonate [Moles/volume] in Arterial blood

553

2866

2.04

48.99

9.5

7.0

24.70

24.54

mmol/l

0.37

535

2719

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1484

10324

1.61

48.33

2.9

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1358

9272

1.63

47.64

1.7

21422500.51

30048851.27

pmol/l

0.27

1097

7641

(3014007) Fractional oxyhemoglobin in Arterial blood

543

2823

2.03

47.64

12.1

9.1

93.22

93.92

1.39

537

2814

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4267

37771

1.70

47.10

5.7

4.6

1.90

2.12

mu/l

1.88

3912

34303

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4606

41714

1.87

46.44

27.3

15.2

27.21

25.02

mg/l

4.42

4141

33370

(40758558) Short blood count panel - Blood

1513

10745

1.57

44.42

8.3

6.8

—

(3021901) Oxygen saturation in Capillary blood

232

860

2.78

44.13

3.3

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

2554

20361

1.50

43.38

4.6

3.8

0.00

estimate

2.17

570

4094

(3009261) Glucose [Presence] in Urine by Test strip

2576

20573

1.50

43.36

4.7

3.8

0.00

estimate

1.72

532

3701

(3021601) Nitrite [Presence] in Urine by Test strip

2549

20323

1.50

43.21

6.1

5.0

0.00

estimate

0.50

559

3828

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

323

1419

2.36

43.15

2.5

3.3

34.48

59.43

mg/l

1.68

259

1154

(3034860) Kappa light chains.free [Mass/volume] in Serum

323

1421

2.36

43.01

2.5

3.3

47.64

100.56

mg/l

0.72

258

1152

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1264

8672

1.60

42.71

4.9

3.8

281.04

522.13

ng/l

1.29

1059

7028

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

322

1419

2.35

42.70

1.6

377.14

297.14

titre

0.17

(3007164) IgA [Mass/volume] in Serum or Plasma

1130

7562

1.63

42.23

1.6

1.5

2.43

2.51

g/l

0.66

715

4520

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

314

1387

2.34

41.40

2.5

3.2

1.84

2.35

ratio

0.29

109

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1182

8056

1.60

40.78

3.0

3.1

2.46

2.45

mmol/l

0.45

999

7031

(3004119) Hemoglobin [Mass/volume] in Venous blood

511

2745

1.95

40.58

5.7

3.4

128.01

128.28

g/l

0.09

501

2673

(3019550) Sodium [Moles/volume] in Serum or Plasma

4690

43092

1.85

39.86

31.6

17.7

139.31

139.63

mmol/l

11.44

4614

41970

(3017143) Hepatitis C virus Ab [Presence] in Serum

714

4291

1.77

39.64

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

429

2185

2.05

39.58

4.2

3.5

25.16

25.26

mmol/l

0.22

416

2115

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

271

1145

2.44

39.46

1.6

1.4

12.71

16.10

iu/ml

—

(3011288) Drugs identified in Urine by Screen method

212

798

2.73

39.15

5.1

3.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

354

1691

2.17

38.63

1.7

1.8

39.65

38.86

u/l

0.28

316

1478

(3033658) Prothrombin time (PT) actual/Normal

1505

10947

1.53

38.58

5.9

4.1

87.69

87.89

0.10

1456

10681

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

200

4.61

38.44

1.8

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4692

43212

1.83

38.21

31.8

17.8

3.98

mmol/l

0.94

4618

42016

(3015736) pH of Urine

2101

16381

1.47

38.21

4.3

3.4

5.87

5.82

0.27

1058

(3020891) Body temperature

368

1800

2.12

37.78

6.6

4.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

1747

2.13

36.97

1.6

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

1748

2.13

36.91

1.6

2.2

7.34

7.44

g/l

0.53

306

1571

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

339

1623

2.16

36.76

1.6

2.3

3.05

2.98

g/l

0.58

288

1447

(3024928) Oxygen saturation in Venous blood

234

955

2.52

36.70

6.5

3.2

—

(3016018) Differential panel - Cerebral spinal fluid

135

409

3.36

36.47

1.9

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

231

941

2.52

36.37

3.5

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

1746

2.11

35.90

1.6

2.2

3.58

3.68

g/l

0.79

304

1571

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

1635

2.14

35.69

1.6

2.3

9.92

10.24

g/l

0.62

287

1445

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

195

742

2.69

35.26

1.4

1.2

45.83

43.02

u/ml

0.10

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

105

278

3.83

34.73

1.1

364.57

299.39

mg/l

0.70

235

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

219

4.21

34.29

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

143

467

3.12

34.18

1.4

1.2

36.93

45.17

u/ml

—

(3021589) Normoblasts [#/volume] in Blood

2301

18520

1.43

34.05

14.7

9.9

0.00

e9/l

0.05

1900

15087

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

763

4857

1.67

33.98

3.4

2.9

9.39

8.98

umol/l

0.18

645

4222

(46235355) HIV 1 and 2 tests - Meaningful Use set

910

6059

1.61

33.85

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

292

1361

2.21

33.83

1.6

2.1

36.88

37.44

g/l

0.72

240

1181

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2417

19645

1.43

33.78

3.1

2.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

111

312

3.61

33.67

1.3

2.17

2.08

mmol/l

0.32

100

296

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1486

2.15

33.48

1.7

2.3

0.51

1.01

g/l

2.25

256

1268

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

478

2676

1.87

33.26

2.5

2.4

22.19

21.78

au/ml

0.02

195

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

105

288

3.70

33.02

1.2

1.1

49.56

44.30

mg/l

0.31

236

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1078

7505

1.55

32.97

3.5

2.8

1.22

1.11

e6/l

0.46

663

4303

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

203

4.24

32.36

2.8

2.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

443

2449

1.88

32.03

14.2

10.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

781

5076

1.63

31.90

1.7

1.6

—

(3016879) Cocaine [Presence] in Urine

249

1119

2.29

31.49

3.7

2.3

—

(3036180) Methadone [Presence] in Urine

170

4.52

31.46

2.1

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

261

1197

2.24

31.44

3.6

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

276

1297

2.19

31.32

3.7

3.3

—

(3017732) Neutrophils [#/volume] in Blood

495

2860

1.81

31.03

4.5

3.0

4.90

5.30

e9/l

0.27

359

2286

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

437

2430

1.87

31.00

1.4

1.3

89.81

53.42

au/ml

1.11

137

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

130

5.05

30.75

2.3

2.2

142.20

154.38

nmol/l

0.41

112

(3018405) Lactate [Moles/volume] in Arterial blood

320

1605

2.06

30.65

5.2

3.9

1.44

1.38

mmol/l

0.33

314

1580

(3037756) Immunofixation for Serum or Plasma

219

942

2.38

30.64

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

116

357

3.30

30.61

1.1

—

(3028300) Cannabinoids [Presence] in Urine

260

1210

2.21

30.22

3.7

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1464

11037

1.45

29.88

5.1

4.1

0.00

estimate

1.54

505

3646

(3027008) Opiates [Presence] in Urine

258

1205

2.20

29.72

3.6

2.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

378

2033

1.93

29.67

4.9

4.1

50.48

48.76

0.69

370

2008

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

267

3.64

29.61

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

137

475

2.93

29.53

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

587

3611

1.70

29.49

4.2

4.1

0.93

0.92

0.05

258

1284

(3002179) Metamyelocytes/100 leukocytes in Blood

546

3296

1.73

29.37

3.9

4.0

0.96

0.69

0.65

240

1114

(3008295) Osmolality of Serum or Plasma

133

462

2.93

28.58

1.4

283.00

278.56

mosm/kgh2o

0.99

110

342

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

777

5188

1.58

28.11

4.4

4.5

32.52

32.43

0.07

555

3494

(3047181) Lactate [Moles/volume] in Blood

287

1434

2.06

27.76

8.3

6.3

1.52

1.31

mmol/l

1.98

248

1268

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

215

3.86

27.56

1.6

—

(3023410) Appearance of Cerebral spinal fluid

118

392

3.06

27.45

2.0

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

556

3434

1.69

27.44

4.3

4.1

0.07

0.11

0.68

227

1108

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

208

922

2.31

27.18

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

995

7069

1.50

27.03

3.8

3.0

3.32

2.22

e6/l

2.56

587

3895

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

253

1218

2.13

27.00

1.7

2.2

0.00

g/l

-0.00

230

1106

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

266

1306

2.09

26.96

1.7

2.2

0.01

0.02

g/l

0.73

243

1189

(3006184) Hemoglobin [Mass/volume] in Capillary blood

222

1022

2.22

26.51

2.5

2.2

130.86

128.46

g/l

0.70

185

733

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

789

5368

1.55

26.14

12.1

7.3

—

(3038026) Centromere Ab [Units/volume] in Serum

102

320

3.23

26.13

1.3

1.2

25.06

59.61

u/ml

—

(3025159) Blasts/100 leukocytes in Blood

525

3240

1.69

25.93

4.2

4.1

0.03

0.31

1.45

193

921

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

304

1589

1.97

25.91

3.9

3.5

0.30

0.34

u/ml

1.80

170

914

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

203

3.83

25.70

1.1

1.05

1.15

u/l

0.36

106

(40760888) Immunoglobulin light chains.free panel - Serum

227

1072

2.17

25.45

2.5

3.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

246

1200

2.10

25.37

1.7

2.2

0.00

g/l

-0.00

230

1104

(3007566) Smooth muscle Ab [Titer] in Serum

233

1115

2.14

25.26

1.2

1.3

134.35

95.28

titre

0.32

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

617

3994

1.62

25.24

3.0

232.60

223.49

ng/l

0.17

558

3623

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

209

959

2.23

25.16

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

209

959

2.23

25.16

1.4

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

231

3.59

24.87

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

201

3.77

24.47

1.7

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

201

3.77

24.47

1.7

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

173

741

2.38

24.47

1.5

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1281

9716

1.42

24.40

4.5

3.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

130

487

2.71

24.31

1.2

1.1

—

(40761535) Cells panel - Urine sediment

559

3563

1.64

24.30

4.6

3.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

315

3.15

24.15

1.2

68.42

50.67

u/ml

0.30

(3027944) Amphetamines [Presence] in Urine

240

1182

2.08

24.13

3.3

2.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

611

3988

1.60

24.10

3.1

2.4

74.93

49.49

u/l

0.30

504

3414

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

312

3.15

23.88

1.2

97.38

69.15

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

679

4553

1.56

23.85

5.0

3.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

297

3.20

23.84

1.3

1.2

2.33

3.84

u/ml

0.69

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2833

24467

1.34

23.62

3.0

2.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

157

4.11

23.60

1.2

1.1

480.13

226.15

ng/l

0.28

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

290

3.21

23.43

1.6

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

153

633

2.46

23.37

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

393

2305

1.76

23.25

2.9

3.2

4.34

4.46

pmol/l

1.45

336

2030

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

284

3.21

22.88

1.6

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

222

1084

2.09

22.85

1.4

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1138

8542

1.42

22.74

1.3

1.59

1.87

u/ml

0.35

266

2188

(3009508) Creatinine [Moles/volume] in Urine

1699

13642

1.36

22.66

3.6

3.2

6.91

7.60

mmol/l

8.34

1414

11464

(3042517) Benzodiazepines panel - Urine

9.35

22.63

2.0

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

126

487

2.63

22.19

3.5

4.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

143

588

2.47

22.15

8.3

6.9

11.57

11.83

mg/l

0.24

126

545

(3037121) Protein [Mass/volume] in Urine

284

1533

1.90

22.00

3.0

3.2

0.35

0.30

g/l

0.55

142

658

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

279

1500

1.91

21.87

2.5

2.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

130

518

2.55

21.52

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

131

524

2.54

21.52

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

223

1116

2.04

21.49

1.2

1.3

917.14

1119.63

titre

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

116

438

2.69

21.41

1.1

—

(3016038) Potassium [Moles/volume] in Urine

302

3.05

21.28

1.3

31.62

35.42

mmol/l

0.90

261

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

131

528

2.52

21.18

1.5

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

198

3.57

21.15

15.4

10.8

0.64

0.62

mmol/l

0.26

182

(3025468) Yersinia sp identified in Specimen by Organism specific culture

129

517

2.53

21.11

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

239

1240

1.97

20.82

1.4

255.49

274.96

ug/g

0.76

131

737

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

517

2.51

20.62

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

117

453

2.62

20.56

3.0

3.6

61.40

56.49

1.54

381

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

519

2.50

20.45

1.6

1.4

—

(3044927) Protein electrophoresis panel - Urine

117

455

2.61

20.38

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

148

643

2.34

20.32

1.6

0.58

0.84

g/l

2.96

115

499

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

544

3592

1.57

20.28

5.5

3.9

1.21

1.22

mmol/l

2.95

485

3139

(3006653) Thiamine [Moles/volume] in Blood

204

3.46

20.23

1.2

1.3

151.04

134.54

nmol/l

1.50

204

(3011412) CD3 cells [#/volume] in Blood

106

394

2.73

20.19

2.6

2.5

1.15

1.13

e9/l

0.11

355

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1892

15651

1.33

20.03

5.1

4.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

114

4.33

19.41

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

112

437

2.60

19.40

2.6

2.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

207

1050

2.01

19.24

1.8

1.9

12.21

11.54

mg/l

0.39

194

966

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

115

4.29

19.19

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

273

3.04

19.11

2.9

2.7

489.61

524.31

e6/l

0.23

228

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

4.14

19.08

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.03

19.01

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

147

3.84

18.89

1.2

1.1

1749.68

1537.64

miu/ml

0.59

147

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

222

1162

1.95

18.87

3.8

4.4

1.91

1.56

mg/l

4.15

200

1066

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

121

4.16

18.83

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

282

2.97

18.68

2.6

2.5

655.49

654.20

e6/l

0.01

271

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

261

3.02

18.04

2.9

2.8

0.21

e9/l

0.05

226

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

148

3.75

17.93

2.2

1.5

6317020.00

1471331.82

iu/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

123

523

2.38

17.78

5.3

18.8

6.75

7.42

mmol/l

1.80

104

438

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.62

17.71

1.2

—

(40761511) CBC panel - Blood by Automated count

4555

43053

1.45

17.40

25.4

14.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

175

867

2.05

17.38

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4654

44188

1.48

17.18

15.6

10.6

31.79

26.54

u/l

18.89

4505

42479

(40768797) Stomach Pathology biopsy report

782

5746

1.42

17.09

1.4

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

4.90

17.06

1.1

—

(4035726) Immunohistochemistry procedure

545

3740

1.51

16.94

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

314

1890

1.70

16.90

7.8

5.3

1.75

1.64

0.89

290

1762

(3019150) Specific gravity of Urine by Refractometry

1147

8995

1.35

16.88

5.2

4.2

1.02

kg/l

0.01

158

1359

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

155

3.58

16.78

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.56

16.54

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

355

2223

1.64

16.43

1.3

—

(1761868) Lipid panel - Serum or Plasma

1104

13835

0.74

16.30

3.2

2.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

117

3.96

16.24

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

425

2787

1.57

16.24

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4175

39004

1.35

16.13

22.7

14.3

79.97

78.97

ml/min/173m2

1.60

3659

32241

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

140

657

2.16

16.05

1.5

1.3

—

(3000494) Fungus identified in Specimen by Culture

679

4919

1.44

15.98

1.6

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.88

15.68

1.5

1.1

10.75

10.49

u/l

0.03

(3035637) Corticotropin [Mass/volume] in Plasma

117

515

2.30

15.67

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

122

547

2.26

15.65

2.6

2.1

27.44

22.45

mg/l

0.39

135

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

139

658

2.14

15.60

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

199

1078

1.88

15.30

1.6

—

(40761536) Microorganisms panel - Urine sediment

507

3499

1.50

15.29

5.3

4.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

174

3185

0.53

15.24

1.6

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

752

2.05

15.20

1.3

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

290

2.72

14.95

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

290

2.72

14.95

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

290

2.72

14.95

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

221

2.97

14.69

1.4

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

293

2.69

14.66

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

293

2.69

14.66

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

293

2.69

14.66

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

6.12

14.64

1.5

2.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

150

3.42

14.63

2.8

2.7

28.66

29.25

umol/l

0.10

110

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

468

2.31

14.58

1.8

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

208

1163

1.82

14.48

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

191

1040

1.87

14.47

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

226

1296

1.78

14.46

1.8

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

150

756

2.01

14.28

3.1

3.6

1.32

1.54

0.27

124

668

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

159

821

1.97

14.14

4.0

3.9

58.75

58.01

0.31

159

821

(3028192) IgG subclass 2 [Mass/volume] in Serum

396

2.40

13.95

1.5

1.4

3.05

2.93

g/l

0.28

287

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.02

13.84

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.32

13.70

1.1

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.11

13.61

2.0

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

154

798

1.96

13.57

3.9

3.5

4.28

4.18

e9/l

0.21

154

798

(3024139) IgG subclass 3 [Mass/volume] in Serum

396

2.37

13.50

1.5

1.4

0.32

0.41

g/l

2.10

285

(3027135) IgG subclass 1 [Mass/volume] in Serum

397

2.37

13.42

1.5

1.4

6.06

6.72

g/l

1.17

286

(21494755) Public health laboratory ask at order entry panel

188

3234

0.57

13.25

1.3

1.4

—

(4062490) Immunoglobulin typing, IgG

400

2.35

13.20

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

106

485

2.21

13.02

2.5

2.4

1.32

1.37

g/24h

0.07

247

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

3.82

12.86

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

857

1.89

12.80

6.0

5.9

929.17

2242.21

iu/ml

0.33

126

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

431

2.27

12.79

1.8

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

309

2.51

12.72

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

294

1875

1.60

12.65

7.9

5.4

0.90

0.89

0.22

275

1752

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4074

38282

1.29

12.64

6.7

5.9

40.43

40.19

mmol/mol

0.77

3686

35236

(3039000) Anion gap in Blood

181

1014

1.81

12.57

10.7

7.3

12.01

11.26

mmol/l

1.51

163

902

(3018572) Chloride [Moles/volume] in Blood

181

1015

1.81

12.53

10.7

7.3

104.44

105.08

mmol/l

0.87

163

903

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

5.23

12.47

4.2

4.6

45.90

56.56

ug/min

0.27

(3022493) Free Hemoglobin [Mass/volume] in Plasma

193

2.92

12.41

1.1

5.8

72.12

71.02

mg/l

0.03

139

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

212

1252

1.72

12.29

4.7

2.8

3.44

3.54

g/l

0.48

204

1191

(3023420) DNA double strand Ab [Units/volume] in Serum

401

2.29

12.25

2.3

1.3

24.18

25.13

iu/ml

0.07

(3045424) Erythrocytes [Presence] in Urine

136

702

1.96

12.16

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

166

917

1.84

12.08

1.7

1.8

5.12

4.81

iu/l

0.09

305

(3012516) Albumin [Mass/volume] in Urine

1525

12909

1.26

11.91

3.5

3.2

653.07

318.24

mg/l

1.44

1023

8352

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

238

2.67

11.79

1.2

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

130

675

1.95

11.45

2.8

3.1

776.20

1627.91

u/ml

—

(3051611) Lipemic interference index of Serum or Plasma

439

2.19

11.44

3.4

3.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

206

1234

1.70

11.36

1.6

0.49

7.99

iu/ml

0.87

272

(3023419) Bacteria identified in Sputum by Culture

127

660

1.95

11.17

2.3

2.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

348

2.32

11.13

1.8

2.4

44.83

37.86

3.53

342

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

299

2.43

11.11

2.4

2.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

147

803

1.85

11.11

1.6

1.7

—

(36660697) Celiac disease serology panel - Serum

436

3116

1.44

10.93

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

284

2.45

10.86

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

598

1.98

10.80

1.3

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

8.25

10.78

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.13

10.77

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

110

2079

0.52

10.71

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

346

2375

1.49

10.69

1.4

1.3

269.50

229.20

u/ml

0.37

318

2177

(3020682) Albumin/Creatinine [Ratio] in Urine

1585

13608

1.24

10.64

4.1

3.8

14.22

10.52

mg/mmol

1.20

1021

8722

(3026493) Urate [Moles/volume] in Serum or Plasma

1351

11400

1.25

10.62

2.9

2.7

4206.89

5035.06

umol/l

0.32

1138

9913

(4200892) Spirometry reversibility

411

2925

1.44

10.54

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

125

660

1.92

10.51

1.3

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

4.48

10.47

1.8

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.63

10.46

2.4

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

136

742

1.86

10.35

1.1

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

137

3.08

10.30

1.2

1.3

3.11

4.07

umol/l

0.97

127

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.54

10.23

2.4

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1293

10903

1.25

10.15

4.3

3.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

825

6591

1.30

10.11

1.3

32.64

33.96

iu/ml

0.08

248

2085

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

585

1.95

10.09

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

280

1873

1.52

9.81

1.9

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

122

656

1.88

9.74

1.5

31.24

31.86

g/l

0.20

112

586

(3000012) Reticulocyte production index

122

657

1.88

9.69

2.0

2.1

—

(40768443) Skin Pathology biopsy report

271

1811

1.52

9.55

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

208

1309

1.61

9.52

2.8

2.7

90.27

90.48

0.04

199

1267

(3036489) Thrombin time

242

1584

1.55

9.38

2.6

2.3

22.25

21.66

0.69

215

1405

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

191

1182

1.64

9.36

3.3

2.7

204.82

194.49

0.74

181

1125

(3013336) Amino acids [Identifier] in Serum or Plasma

12.34

9.34

2.2

2.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

4754

46016

1.36

9.25

39.7

22.2

39.10

40.29

10.18

4452

42849

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

13.67

9.16

1.1

1.0

—

mmol/l

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

216

2.52

9.09

2.0

2.9

101.63

95.59

0.49

205

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

129

723

1.80

9.05

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

129

723

1.80

9.05

1.7

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

188

2.62

8.98

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

174

1066

1.65

8.89

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

107

3.19

8.88

2.8

2.7

112.17

218.30

e6/l

1.48

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

109

583

1.89

8.88

1.5

1.3

0.42

0.31

nmol/l

0.17

(3024731) MCV [Entitic volume]

4754

46059

1.35

8.81

39.0

22.1

91.83

91.15

18.18

4694

45303

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

332

2.18

8.81

2.4

18.91

19.36

nmol/l

0.13

312

(3017569) Oxygen content in Arterial blood

232

2.43

8.77

1.8

2.3

—

(3007461) Platelets [#/volume] in Blood

4752

46041

1.35

8.77

39.2

22.1

247.66

246.61

e9/l

0.48

4662

44755

(3010813) Leukocytes [#/volume] in Blood

4754

46067

1.35

8.73

39.2

22.1

7.22

6.80

e9/l

17.33

4664

44608

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

108

580

1.88

8.70

1.5

1.3

0.66

0.64

nmol/l

0.29

102

550

(3035941) MCH [Entitic mass]

4753

46060

1.35

8.69

38.9

22.0

30.43

30.36

1.68

4692

45304

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

174

2.66

8.68

1.1

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

4754

46075

1.35

8.65

39.5

22.3

130.73

135.32

g/l

69.29

4689

45329

(3026361) Erythrocytes [#/volume] in Blood

4753

46065

1.35

8.64

39.1

22.1

4.34

4.48

e12/l

62.21

4658

44620

(3032057) Clostridioides difficile [Presence] in Stool

104

3.19

8.61

2.0

—

(3019977) pH of Arterial blood

265

2.32

8.61

2.5

7.41

7.42

0.57

(3011985) Renin [Units/volume] in Plasma

106

568

1.88

8.60

1.6

1.4

53.18

57.16

mu/l

0.09

502

(3030981) Hyaline casts [#/volume] in Urine by Automated count

330

2344

1.44

8.58

3.0

2.8

0.32

0.29

e6/l

0.19

324

2287

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

266

2.31

8.54

1.1

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

108

584

1.87

8.52

1.5

18524.67

1971.56

e6/l

1.16

420

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

267

2.30

8.47

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

338

2.15

8.44

1.1

1.2

106.25

164.78

titre

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

524

1.91

8.35

1.5

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4201

40151

1.23

8.20

5.2

4.7

6.08

6.00

mmol/l

3.09

3769

36334

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.35

8.19

1.2

0.63

0.69

umol/24h

0.26

(3026389) Candida sp identified in Specimen by Organism specific culture

101

543

1.88

8.14

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

8.05

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

531

1.88

8.04

1.5

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

140

833

1.70

8.03

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

242

2.33

8.02

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

130

758

1.73

8.02

4.1

3.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

121

2.91

7.84

3.0

2.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

245

2.30

7.81

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

112

631

1.79

7.78

1.4

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

453

3448

1.34

7.78

3.1

2.6

65.20

64.29

ml/min/173m2

0.10

202

1400

(3048689) Calprotectin [Mass/mass] in Stool

588

4645

1.30

7.76

2.1

2.3

157.66

149.59

ug/g

0.19

464

3683

(3028308) Erythrocytes [#/volume] in Pleural fluid

531

1.86

7.73

1.5

37343.40

71869.14

e6/l

1.11

315

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

427

1.96

7.65

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

174

2.54

7.64

3.7

2.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

235

2.31

7.63

3.1

2.6

44.89

39.64

1.51

131

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

229

2.33

7.61

2.2

1.8

1.76

3.06

u/field

0.78

166

(3012441) Differential panel - Pleural fluid

507

1.87

7.53

1.4

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

530

1.85

7.46

1.2

1.3

272.05

299.03

pmol/l

0.38

455

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

383

2.00

7.43

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

117

678

1.74

7.41

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

171

1095

1.58

7.37

2.0

1.6

339.75

299.79

mu/l

0.64

155

1007

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

365

2.01

7.30

1.4

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

135

817

1.67

7.30

1.3

—

(3028433) Virus identified in Specimen by Culture

149

2.63

7.27

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

149

2.63

7.27

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

421

1.94

7.26

1.2

1.1

62.46

67.16

u/l

0.18

378

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.14

7.26

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

514

1.84

7.23

1.5

1.3

—

nmol/l

—

(3049233) Organic acids panel - Urine

15.75

7.22

1.2

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

382

1.98

7.14

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

382

1.98

7.14

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

382

1.98

7.14

1.8

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.05

7.07

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

1157

1.55

6.99

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

165

2.50

6.90

1.6

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

332

2.03

6.89

1.0

281.02

285.62

mg/l

0.17

296

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.97

6.88

2.5

2.8

0.74

0.52

u/field

0.37

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

103

2.92

6.83

1.1

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

273

2.14

6.83

1.1

1.3

66.00

61.90

titre

—

(40768446) Kidney Pathology biopsy report

166

2.48

6.82

1.5

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.09

6.76

5.1

7.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

115

2.79

6.72

1.1

1.3

159.86

142.34

nmol/l

0.20

(21494890) Protein electrophoresis panel - 24 hour Urine

462

1.85

6.69

1.8

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

319

2355

1.38

6.69

1.3

1.2

119.35

142.30

iu/ml

0.41

839

(3003327) Ova and parasites identified in Stool by Light microscopy

188

1261

1.51

6.61

1.9

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

181

2.39

6.60

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.57

6.58

2.7

2.1

15.79

17.09

umol/l

0.25

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

360

1.96

6.52

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

569

1.75

6.50

1.1

1.56

1.52

g/l

0.46

505

(3009214) Lutropin [Units/volume] in Serum or Plasma

156

1009

1.56

6.48

1.7

1.4

9.22

9.18

u/l

0.01

123

817

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.65

6.46

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

2.60

6.44

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

152

980

1.57

6.41

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

287

2.07

6.41

1.2

1.3

80.00

408.21

titre

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

122

746

1.65

6.39

1.4

1.5

103.29

114.92

u/ml

0.71

143

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

102

2.85

6.35

1.3

1.5

0.30

0.43

ug/l

0.90

(3042631) Mycobacterium sp identified in Specimen

105

618

1.71

6.35

2.3

2.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

110

657

1.69

6.31

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

152

985

1.56

6.28

1.6

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

177

1187

1.51

6.25

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

556

1.74

6.16

2.0

2.2

32.43

32.56

0.10

551

(40768806) Pleura Pathology biopsy report

513

1.77

6.10

1.7

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

133

2.57

6.10

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

259

2.10

6.10

1.5

6.91

6.60

u/l

0.04

212

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

134

850

1.59

6.08

2.1

2.2

3192.15

3964.32

u/l

0.14

330

(3016750) Collection duration of Urine

253

2.11

6.07

2.3

2.0

515.73

487.89

min

1.16

185

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

175

1180

1.50

6.04

1.5

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.87

5.98

1.0

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.85

5.93

1.2

1.1

267.36

292.45

pmol/l

0.13

(42529406) Shigella sp [Presence] in Stool by Culture

177

1202

1.49

5.91

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

176

1194

1.49

5.90

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

160

2.39

5.86

1.8

3.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.20

5.86

1.5

2.0

—

(3011648) Oxygen content in Venous blood

360

1.90

5.85

4.3

3.0

11.77

11.02

0.89

360

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

333

1.93

5.80

1.2

1.5

30.38

24.18

u/ml

0.40

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.87

5.77

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

893

0.48

5.73

1.8

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

122

769

1.60

5.71

1.3

307.83

273.99

u/ml

0.55

460

(3004775) Volume in Urine collected for unspecified duration

351

1.89

5.62

2.3

2.2

679.35

629.96

0.49

225

(3027456) Digoxin [Moles/volume] in Serum or Plasma

148

979

1.53

5.61

3.0

3.2

0.90

0.83

nmol/l

0.46

113

736

(3000093) Morphology [Interpretation] in Blood Narrative

424

1.80

5.57

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

262

2.03

5.56

3.5

3.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

129

2.49

5.44

1.3

8.42

387.71

ug/l

1.06

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.34

5.43

1.1

1.2

25.29

59.91

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

736

6225

1.21

5.30

1.3

1.2

11.01

13.06

u/ml

0.28

237

2372

(3017509) Phencyclidine [Presence] in Urine

4.72

5.29

2.6

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

227

2.08

5.27

2.1

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

227

2.08

5.27

2.1

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

156

1059

1.49

5.26

1.7

1.6

13757.81

13876.39

e6/l

0.01

116

764

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

149

1004

1.50

5.21

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

413

1.78

5.14

1.4

1.3

22.76

26.15

u/l

0.41

335

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

298

1.92

5.14

1.0

314.40

313.86

ng/l

0.00

199

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.94

5.13

1.6

1.7

127.95

155.33

ng/l

0.40

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

299

1.92

5.09

1.0

34.82

43.84

ng/l

1.16

196

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

285

1.94

5.09

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

13.35

5.07

1.3

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

604

1.63

5.06

1.1

1.2

2.97

4.17

u/ml

0.40

204

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

8.35

5.05

1.5

1.0

1.90

2.33

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

178

2.20

5.05

2.1

1.9

—

(3017704) Immunofixation for Urine

245

2.01

5.02

2.0

1.6

—

(3022145) Colonoscopy Study observation

558

4614

1.23

5.02

1.4

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

499

1.69

5.00

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

499

1.69

5.00

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

239

2.02

4.98

1.3

1.84

1.16

nmol/l

2.05

183

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.63

4.97

1.1

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

592

1.63

4.96

1.1

1.2

3.00

4.49

u/ml

1.27

264

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

2.26

1.36

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

3.65

3.55

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

0.64

1.21

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

3.99

2.70

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

1.87

2.60

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

5.61

2.29

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.43

4.90

1.5

4.99

3.28

mg/l

—

(3012565) Volume of 24 hour Urine

207

2.09

4.88

2.0

2.5

2415.79

1954.54

0.77

178

(3007463) Buprenorphine [Presence] in Urine

7.70

4.84

11.4

4.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

320

1.85

4.79

1.2

1.3

—

titre

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

299

1.88

4.77

1.0

603.91

718.82

ng/l

0.96

193

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

176

2.17

4.77

2.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

176

2.17

4.77

2.1

2.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.21

4.76

1.5

1.88

1.75

mg/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

1026

1.47

4.72

1.1

9.12

6.84

u/ml

0.17

111

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.95

4.70

1.7

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

5.46

4.59

1.0

1.2

52.71

32.75

—

(3020961) Endomysium IgA Ab [Titer] in Serum

235

1761

1.35

4.58

1.1

162.00

174.90

titre

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

240

1.97

4.58

1.2

1.1

32.68

20.27

u/l

1.32

201

(3003338) MCHC [Mass/volume]

3345

34952

0.88

4.53

34.3

19.5

330.88

332.46

g/l

17.05

3305

34631

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.16

4.48

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

3707

35612

1.14

4.41

29.9

18.0

15.57

15.14

1.94

3654

34931

(3010838) Calcium [Moles/time] in 24 hour Urine

108

707

1.54

4.38

1.4

1.8

3.93

4.91

mmol/24h

2.44

605

(3002079) Sodium [Moles/time] in 24 hour Urine

176

2.11

4.37

1.1

1.3

148.30

160.75

mmol/24h

0.40

176

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.10

4.35

1.1

—

(3045788) Cell count panel - Pleural fluid

458

1.67

4.34

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

551

1.61

4.33

1.9

19.61

24.26

ug/l

0.69

542

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.89

4.32

1.3

120.82

75.07

ng/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.89

4.32

1.4

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.01

4.31

1.4

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

191

2.05

4.28

2.4

2.3

52.17

53.35

umol/l

0.07

157

(3052592) Norovirus Ag [Presence] in Stool

2.59

4.13

1.3

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.34

4.12

1.2

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

4.00

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

370

1.71

3.99

2.2

2.1

1.34

1.91

u/field

0.54

138

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

156

2.12

3.99

2.0

2.2

842.00

22208.30

u/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

3.03

3.96

1.5

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

2.48

3.95

1.2

1.3

43.60

62.30

mu/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

125

864

1.46

3.94

1.6

1.9

0.80

0.81

nmol/l

0.02

718

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

501

0.44

3.89

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

295

2338

1.28

3.89

2.5

2.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.79

3.88

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

500

0.44

3.87

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

366

1.70

3.86

1.8

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

499

0.44

3.85

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

498

0.44

3.83

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

249

1.85

3.83

1.3

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

249

1.85

3.83

1.3

1.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.01

3.76

1.0

1.50

1.00

u/field

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.59

3.74

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

543

0.48

3.66

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

119

1680

0.70

3.62

1.8

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

413

0.41

3.56

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

112

776

1.45

3.53

1.5

—

(3044941) Cell count panel - Synovial fluid

102

694

1.48

3.53

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

410

0.41

3.50

1.5

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

591

1.51

3.46

1.8

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

1.74

3.43

1.3

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

553

1.53

3.41

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

113

2.22

3.40

1.2

1.0

—

(3044889) 12 lead EKG panel

3091

29574

1.11

3.40

4.5

3.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

662

1.47

3.32

1.2

1.1

18.55

933.49

iu/ml

0.54

145

(3017315) Amylase [Enzymatic activity/volume] in Urine

204

1.87

3.29

1.2

1.3

490.76

346.77

u/l

0.22

191

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

478

1.56

3.28

3.0

3.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

518

1.53

3.28

1.4

1.6

54.08

58.73

0.39

327

(40757373) Influenza virus identified in Isolate

109

2.21

3.24

1.1

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.34

3.19

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.80

3.08

1.0

1.2

20.93

20.11

u/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

283

1.70

3.07

1.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.51

3.05

2.0

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

139

2.02

3.05

1.5

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

423

0.47

2.98

1.5

—

(40768800) Prostate Pathology biopsy report

1025

0.66

2.98

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.24

2.96

1.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

233

1863

1.26

2.93

1.3

—

(3047189) Immunofixation for 24 hour Urine

220

1.78

2.92

1.6

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.70

2.88

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

409

1.55

2.79

2.0

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

418

1.54

2.76

1.6

1.3

131770.31

113747.18

e6/l

0.09

294

(3043410) Blood group antigens tested for on Red Blood Cells

125

2.00

2.70

2.2

1.8

—

(40768804) Tissue Pathology biopsy report

1778

16693

1.10

2.65

2.2

2.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

140

1.93

2.64

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.79

2.64

1.9

1.2

—

13.41

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

406

3478

1.18

2.61

2.6

2.2

12.00

12.82

nmol/l

1.20

358

3097

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.61

1.1

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

221

1.72

2.60

1.1

1.10

1.05

ratio

1.04

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.67

2.59

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

425

1.51

2.58

1.6

1.4

0.23

0.32

nmol/l

1.80

326

(4146454) Self-monitoring of blood glucose

482

1.48

2.58

2.4

2.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

573

1.44

2.57

1.1

124.49

114.44

1.48

516

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

402

1.52

2.55

2.1

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

142

1.91

2.55

3.3

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

142

1.91

2.55

3.3

2.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.60

2.53

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

131

994

1.33

2.51

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.38

2.47

1.1

1.0

—

(3022621) pH of Urine by Test strip

331

2807

1.19

2.41

3.2

3.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

181

1443

1.26

2.40

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.64

2.36

4.1

5.4

—

(3042733) HLA Ab [Presence] in Serum

139

1.87

2.36

4.9

4.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

125

1.92

2.35

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

161

1.81

2.34

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

169

1343

1.27

2.31

1.7

1.4

23.72

28.10

iu/l

1.10

131

1131

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.48

2.27

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.48

2.27

1.0

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

313

2658

1.19

2.26

1.6

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.89

2.25

1.3

1.5

22.33

15.23

nmol/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.28

2.24

4.9

1.9

1.40

1.90

mmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

927

0.70

2.22

1.3

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.56

2.21

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

248

1.62

2.21

1.4

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

592

1.39

2.19

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.50

2.18

1.2

1.3

1.91

1.73

umol/24h

0.31

(3014051) Protein [Presence] in Urine by Test strip

143

1123

1.28

2.17

3.1

2.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

226

1.64

2.17

2.0

3.2

31.97

25.29

mu/l

0.32

215

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

265

1.59

2.17

1.3

0.52

1.91

u/ml

1.73

153

(3035880) pH of Pleural fluid

273

1.58

2.16

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

211

1.66

2.16

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

139

1091

1.28

2.13

2.5

2.2

185.33

105.31

ug/min

1.08

671

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

387

1.48

2.13

1.0

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.00

2.10

2.1

1.3

—

(3001556) Androgen free Index in Serum or Plasma

3.20

2.09

1.8

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.00

2.07

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

119

921

1.30

2.04

1.9

219.89

203.03

pmol/l

0.51

110

875

(3049717) Cytology report of Urine Cyto stain

216

1792

1.21

2.04

2.1

2.7

—

(3006270) Folate [Moles/volume] in Blood

391

1.46

2.03

1.3

1.2

364.16

354.33

nmol/l

0.14

333

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

339

2930

1.17

2.02

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

224

1.61

1.99

4.1

13.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

240

1.59

1.98

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

240

1.59

1.98

1.3

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

127

1.81

1.93

1.3

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.00

1.90

1.0

1.1

—

6.58

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.18

1.88

1.4

1.0

—

(3034426) Prothrombin time (PT)

136

1.77

1.86

1.1

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.86

1.86

1.1

—

38.80

—

(3032773) Endomysium IgG Ab [Titer] in Serum

325

1.48

1.85

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.39

1.85

2.3

3.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

699

1.32

1.83

1.5

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.83

1.82

1.2

1.1

106.48

104.23

0.11

105

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

275

3193

0.85

1.81

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

270

1.52

1.81

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.05

1.80

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.05

1.80

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.92

1.79

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

608

0.67

1.79

3.4

3.9

115.32

31.31

u/ml

0.53

590

(3037692) Legionella sp identified in Specimen by Organism specific culture

161

1.68

1.77

1.1

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

396

1.42

1.75

1.5

1.3

1.56

1.53

nmol/l

0.08

357

(3009015) Lactate [Moles/volume] in Synovial fluid

2.23

1.73

1.3

1.2

10.10

5.78

mmol/l

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.92

1.72

1.1

1.2

—

1.14

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.92

1.72

1.0

1.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

155

1.68

1.72

1.3

1.4

4.10

2.83

0.24

128

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

103

1.85

1.71

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.06

1.70

3.4

5.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

180

1.61

1.66

1.7

3.93

7.34

nmol/l

0.52

151

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

112

1.79

1.64

4.8

6.0

62.13

73.60

—

(3000492) Spirometry study

444

3977

1.13

1.63

1.6

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

402

1.40

1.63

1.4

1.5

13.72

28.77

4.29

245

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

448

4985

0.89

1.61

1.5

1.4

—

(3006462) Nitrate [Presence] in Urine

198

1.57

1.59

5.2

3.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

541

1.34

1.59

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

117

938

1.25

1.58

1.3

267.43

212.59

miu/ml

0.56

400

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

430

1.38

1.58

1.1

1.2

97.34

95.34

0.20

407

(3009871) Measles virus Ab [Titer] in Serum

121

1.74

1.58

1.6

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

153

1264

1.22

1.57

1.8

38.46

41.07

nmol/l

0.61

147

1220

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.76

1.56

1.1

97.77

88.65

0.74

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

365

3240

1.14

1.56

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

504

4564

1.12

1.54

3.1

4.0

14.05

25.69

ug/l

1.33

391

3747

(3050794) Legionella sp Ab [Presence] in Serum

2.43

1.53

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.34

1.52

1.2

1.1

160.20

294.07

nmol/l

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.86

1.50

3.7

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

608

0.70

1.50

1.5

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

116

1.73

1.48

6.8

7.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.73

1.43

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

125

1.68

1.43

1.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

868

9280

0.92

1.40

2.7

3.0

0.68

0.79

ug/l

3.16

600

6248

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.42

1.39

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.89

1.38

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

758

1.26

1.38

1.2

22.50

47.07

u/l

3.13

656

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

280

1.43

1.37

2.4

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

529

1.31

1.36

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.94

1.36

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

112

1.70

1.35

1.4

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.76

1.34

2.8

1.7

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

191

1.52

1.34

1.3

1.4

58.59

64.42

0.37

152

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.04

1.32

1.4

2.2

—

(3046861) Legionella sp Ag [Presence] in Urine

2.78

1.28

1.2

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.67

1.28

1.1

1.2

97.17

86.39

1.13

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.05

1.26

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1682

16141

1.06

1.26

4.4

4.9

3.28

3.62

ug/l

0.26

1475

14466

(3036071) Salmonella sp Ab [Titer] in Serum

130

1.62

1.26

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

151

1280

1.19

1.24

1.6

1.9

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.00

1.23

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.63

1.21

1.4

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.16

1.21

1.3

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

137

1155

1.19

1.21

5.2

4.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.75

1.18

1.4

1.9

—

(3024263) Appearance of Synovial fluid

247

1.42

1.18

1.3

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.11

1.18

7.0

4.1

—

(3022689) Creatine [Moles/volume] in Urine

128

0.47

1.16

1.3

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.15

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

223

0.58

1.15

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

134

1.57

1.14

1.5

1.2

46.31

39.11

g/l

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

335

1.35

1.13

1.4

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

103

1.65

1.12

5.6

7.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.34

1.12

3.9

5.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.73

1.08

1.6

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

164

0.55

1.08

1.1

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.71

1.05

1.2

1.4

9.25

5.67

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.63

1.03

1.2

1.93

1.63

mmol/l

0.37

(3048879) Bone marrow aspiration report

130

1.54

1.02

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

1.56

1.02

1.1

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.69

1.01

1.4

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.88

1.00

1.3

1.2

—

(3025577) Chromium [Mass/volume] in Blood

274

1.35

0.98

1.9

2.1

1.94

2.00

ug/l

0.06

232

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.17

0.98

1.4

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.97

0.0

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.63

0.97

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.69

0.95

1.2

0.45

2.24

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.89

0.94

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

662

6230

1.07

0.93

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

314

1.31

0.89

1.9

1.5

—

(3004451) EKG impression Narrative

236

1.36

0.89

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

288

1.32

0.89

2.0

1.5

70.55

85.89

umol/l

2.75

288

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

127

1.50

0.88

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

289

0.69

0.88

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

153

1.44

0.85

1.4

1.3

75.29

58.94

1.78

127

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

113

0.53

0.83

1.0

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.74

0.82

1.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

197

1.37

0.82

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.55

0.81

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

172

1.40

0.80

1.0

1.1

98.26

94.52

0.12

134

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

1.49

0.79

1.1

1.3

30.00

33.12

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.79

0.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

592

1.20

0.78

2.6

2.7

4.57

780.00

u/ml

0.94

581

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

131

1.45

0.78

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.59

0.78

5.8

7.4

—

(3044009) aPTT.lupus sensitive (LA screen)

1.77

0.76

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.60

0.74

3.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

0.74

1.6

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.08

0.74

1.0

—

(3000330) Specific gravity of Urine by Test strip

243

2220

1.10

0.74

4.4

3.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

443

1.22

0.72

1.6

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.58

0.71

1.0

1.1

77.87

71.78

ug/l

—

(3008037) Lactate [Moles/volume] in Venous blood

117

1028

1.14

0.70

4.4

3.3

1.81

1.64

mmol/l

0.72

111

999

(3038177) Helicobacter pylori Ab [Presence] in Serum

619

1.18

0.69

1.2

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

500

1.20

0.69

3.0

3.3

3.69

16.96

nmol/l

0.64

488

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.67

0.68

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.53

0.68

16.1

12.9

3.66

5.96

mmol/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

205

1.32

0.67

1.3

6.04

5.94

mmol/l

0.12

194

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1252

12922

0.96

0.65

3.7

4.3

22.17

21.93

0.19

593

6354

(3025018) Bordetella pertussis Ab [Titer] in Serum

224

1.30

0.64

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

120

1.42

0.64

1.4

9.42

8.87

ug/l

0.23

120

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.50

0.63

2.1

1.3

—

(3033799) Differential panel - Peritoneal fluid

139

1.37

0.60

2.9

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

209

0.72

0.59

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

115

1288

0.89

0.59

1.6

1.7

4.34

4.07

mg/l

0.06

942

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.51

0.58

1.9

1.6

43.13

43.30

umol/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.72

0.57

4.3

2.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1031

0.88

0.57

1.2

1.4

—

(3020491) Glucose [Moles/volume] in Blood

318

0.79

0.55

1.5

2.2

6.24

6.75

mmol/l

1.01

214

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.42

0.54

2.4

2.3

—

(3015183) Erythrocyte sedimentation rate

182

0.71

0.54

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.50

0.51

5.3

2.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.41

0.51

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.41

0.51

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.41

0.51

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

236

0.76

0.50

5.3

6.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

576

1.15

0.49

3.6

2.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.43

0.49

1.0

1.2

—

98.43

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

244

1.23

0.48

2.9

4.0

—

(3044007) Cell count panel - Peritoneal fluid

128

1.33

0.47

2.6

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

218

1.24

0.46

3.8

3.4

—

(3003694) ABO and Rh group [Type] in Blood

1136

11064

1.03

0.46

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

505

1.15

0.45

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

157

1.27

0.43

2.7

2.2

970.08

5247.83

e6/l

0.45

118

(3034891) Synovial lining cells/100 cells in Synovial fluid

203

1.23

0.42

1.3

1.4

0.80

4.11

—

(3003740) Influenza virus B Ag [Presence] in Specimen

552

0.87

0.41

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.41

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.41

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.41

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.41

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.41

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.36

0.41

1.0

1.2

—

(44813793) Dust mix specific IgE antibody measurement

241

1.20

0.40

1.1

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.39

1.6

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

907

0.90

0.39

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.41

0.39

1.1

1.0

—

(3019174) dRVVT (LA screen)

1.39

0.38

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

334

0.84

0.38

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

312

0.83

0.37

1.8

1.2

—

(3008898) HLA-B27 [Presence]

129

1194

1.08

0.37

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

336

1.16

0.37

3.2

4.9

62.51

78.37

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

101

928

1.09

0.35

2.2

3.4

345.90

759.68

u/ml

0.61

851

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

124

0.73

0.35

2.9

3.2

—

117.97

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

245

1.18

0.35

1.0

1.1

8.11

10.18

iu/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.40

0.35

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

173

1625

1.07

0.35

1.8

2.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.36

0.34

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

510

0.88

0.34

1.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

552

0.89

0.33

1.1

—

(3024471) HLA-A [Type]

145

1.24

0.33

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

100

1.30

0.33

1.5

2.2

6.14

7.96

mmol/l

—

(3001729) Color of Synovial fluid

1.30

0.33

1.3

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.70

0.33

2.7

1.7

—

54.33

—

(40768441) Liver Pathology biopsy report

303

1.16

0.32

1.7

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.28

0.32

33.8

8.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

143

0.77

0.32

1.5

1.1

—

(1002224) Polysomnography panel

144

1535

0.94

0.32

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

101

1.29

0.31

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.32

0.30

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

176

1.19

0.28

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

232

1.16

0.28

2.1

144.00

240.53

ug/min

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

796

1.08

0.28

1.4

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

281

1.14

0.26

2.3

1.6

1.04

0.96

g/l

0.47

281

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.26

0.26

1.2

—

(3024932) HLA-DR beta [Type]

141

1.21

0.26

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.72

0.24

5.7

7.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.72

0.24

2.7

1.5

—

(4034850) Laboratory test

128

1346

0.95

0.21

15.1

10.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

412

1.09

0.20

1.1

2.73

4.44

u/ml

0.53

173

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.20

1.2

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

403

4133

0.97

0.20

1.5

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.22

0.20

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.18

0.19

2.0

6.4

15.00

1012.84

g/mol

—

(3013727) Leukocytes other/100 leukocytes in Blood

156

1.15

0.18

5.0

3.7

57.89

54.17

0.33

150

(3026692) Albumin [Mass/volume] in Peritoneal fluid

119

1.18

0.17

1.1

1.5

11.52

13.24

g/l

—

(40758292) HTLV I+II Ab panel - Serum

1.13

0.17

1.1

1.4

—

(3000285) Sodium [Moles/volume] in Blood

0.74

0.17

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

127

1321

0.96

0.15

1.7

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

380

0.92

0.15

1.1

1.0

0.48

0.32

u/ml

—

130

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4165

41532

1.01

0.15

5.2

5.0

2.61

2.70

mmol/l

8.01

3745

38081

(3035320) C reactive protein [Mass/volume] in Body fluid

294

1.09

0.14

2.2

2.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4020

40316

0.99

0.14

4.7

4.4

1.40

1.44

mmol/l

5.08

3609

36933

(3014599) Egg white IgE Ab [Units/volume] in Serum

180

0.89

0.13

1.0

1.1

11.96

1.87

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

142

1.13

0.12

2.6

2.1

860.43

19167.30

e6/l

—

(3035933) Granulocytes/100 leukocytes in Blood

116

0.86

0.12

1.0

1.4

—

(40768793) Breast Pathology biopsy report

831

0.96

0.10

1.4

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

331

0.94

0.10

1.3

1.4

119.71

194.87

pmol/l

1.59

331

(4094501) Cardiovascular stress test using bicycle ergometer

112

1154

0.97

0.10

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

497

1.05

0.09

1.1

6.46

2.86

u/ml

0.31

202

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

409

1.05

0.09

1.4

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.83

0.08

1.2

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.08

0.08

1.3

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

147

1.09

0.07

1.8

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

422

1.04

0.07

2.6

3.0

43.11

56.30

mg/l

0.22

324

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.83

0.07

1.6

1.5

—

(40765096) Chromosome analysis panel by Banding

129

1.09

0.05

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

247

1.05

0.05

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3890

38947

1.00

0.05

4.3

4.0

1.41

1.30

mmol/l

13.76

3474

35378

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

1.08

0.04

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

387

1.03

0.04

1.8

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

407

1.03

0.04

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

594

0.98

0.04

1.1

5.52

5.20

u/ml

0.05

310

(3034274) Bile acid [Moles/volume] in Serum --fasting

329

1.03

0.03

1.8

2.2

17.71

9.44

umol/l

0.35

228

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4069

40658

1.00

0.03

4.7

4.5

4.49

4.58

mmol/l

7.28

3672

37484

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

182

1.04

0.02

1.2

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

188

0.96

0.02

1.1

24.10

2.77

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

179

1803

0.99

0.02

2.7

3.5

51.08

63.34

u/ml

0.31

174

1736

(3045683) HLA typing for celiac disease panel - Blood or Tissue

218

0.96

0.02

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1098

10997

1.00

0.01

1.7

1.6

1.54

1.37

mmol/l

4.43

939

9218

(3015076) Soybean IgE Ab [Units/volume] in Serum

153

1.05

0.01

1.1

0.74

2.16

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

448

0.98

0.01

1.1

9.05

3.04

u/ml

0.64

221

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

223

1.03

0.01

1.4

1.60

1.55

g/l

0.34

223

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

191

1919

1.00

0.01

1.1

—

(40768795) Lymph node Pathology biopsy report

403

1.02

0.01

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

543

1.01

0.01

1.1

3.31

1.62

u/ml

0.45

291

(3002256) Pathology report gross observation

548

5490

1.00

0.01

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

262

2612

1.00

0.01

1.1

1.2

—

(21494434) Karyotype in Bone marrow

406

0.99

0.00

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

102

0.98

0.00

1.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

452

1.00

0.00

1.3

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

146

1.03

0.00

1.1

—

(4281824) Cell count and differential, peritoneal fluid

404

0.99

0.00

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

158

1584

1.00

0.00

2.7

3.3

101.53

3432.90

u/ml

1.18

132

1352

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

351

1.00

0.00

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

579

1.00

0.00

1.1

0.98

1.39

u/ml

0.22

257

(3051387) C reactive protein [Mass/volume] in Capillary blood

961

1.00

0.00

3.7

3.5

26.11

28.52

mg/l

0.25

606

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.95

0.00

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.0

—

0.24

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.80

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(4212803) Bone marrow aspirate examination

1.00

-0.00

1.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

5.9

—

63.13

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

670

1.00

-0.00

1.2

1.1

1.29

2.24

u/ml

1.13

353

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MYONEU and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MYONEU	2.179 [1.94, 2.45]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.026

During the follow-up period (1.1.1998 — 31.12.2019), 5630 out of 15018 females with G6_MYONEU died.

Males

Parameter	HR [95% CI]	p-value
G6_MYONEU	2.996 [2.64, 3.4]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 7312 out of 17909 males with G6_MYONEU died.

Mortality risk

Mortality risk for people of age

years, who have G6_MYONEU.

N-year risk	Females	Males
1	0.158%	0.431%
5	1.15%	3.041%
10	2.834%	7.753%
15	5.241%	15.018%
20	9.066%	25.303%

Relationships between endpoints

↥

Index endpoint: G6_MYONEU – Diseases of the myoneural junction and muscle

GWS hits: 18

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of the myoneural junction and muscle

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints